<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.ydbio.2020.02.009"><dct:format>application/xml</dct:format><dct:title>Ras2, the TC21/R-Ras2 Drosophila homologue, contributes to insulin signalling but is not required for organism viability</dct:title><dct:creator>Patricia Vega-Cuesta</dct:creator><dct:creator>Ana Ruiz-G&#243;mez</dct:creator><dct:creator>Cristina Molnar</dct:creator><dct:creator>Maria F. Organista</dct:creator><dct:creator>Mart&#237;n Resnik-Docampo</dct:creator><dct:creator>Julia Falo-Sanjuan</dct:creator><dct:creator>Ana L&#243;pez-Varea</dct:creator><dct:creator>Jose F. de Celis</dct:creator><dct:subject><rdf:Bag><rdf:li>Ras</rdf:li><rdf:li>Akt</rdf:li><rdf:li>Erk</rdf:li><rdf:li>InR signalling</rdf:li><rdf:li>Wing disc</rdf:li></rdf:Bag></dct:subject><dct:description>Developmental Biology 461 (2020) 172-183. doi:10.1016/j.ydbio.2020.02.009</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Developmental Biology</prism:publicationName><prism:copyright>&#169; 2020 Elsevier Inc.</prism:copyright><dct:publisher>Elsevier Inc.</dct:publisher><prism:issn>0012-1606</prism:issn><prism:volume>461</prism:volume><prism:number>2</prism:number><prism:coverDisplayDate>15 May 2020</prism:coverDisplayDate><prism:coverDate>2020-05-15</prism:coverDate><prism:pageRange>172-183</prism:pageRange><prism:startingPage>172</prism:startingPage><prism:endingPage>183</prism:endingPage><prism:doi>10.1016/j.ydbio.2020.02.009</prism:doi><prism:url>http://dx.doi.org/10.1016/j.ydbio.2020.02.009</prism:url><dct:identifier>doi:10.1016/j.ydbio.2020.02.009</dct:identifier><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-05-15T01:49:52Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#ElsevierBranded</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://www.elsevier.com/open-access/userlicense/1.0/</oa:userLicense><oa:windowType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/WindowType#OpenArchive</oa:windowType></oa:openAccessInformation><dp:availableOnlineInformation><bam:availableOnline xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2020-02-14T00:00:00.000Z</bam:availableOnline><bam:vorAvailableOnline xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2020-04-28T00:00:00.000Z</bam:vorAvailableOnline></dp:availableOnlineInformation></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="fla" version="5.6" xml:lang="en"><ja:item-info><ja:jid>YDBIO</ja:jid><ja:aid>8213</ja:aid><ce:pii>S0012-1606(20)30060-9</ce:pii><ce:doi>10.1016/j.ydbio.2020.02.009</ce:doi><ce:copyright type="full-transfer" year="2020">Elsevier Inc.</ce:copyright></ja:item-info><ce:floats><ce:figure id="fig1"><ce:label>Fig.&#160;1</ce:label><ce:caption id="cap0020"><ce:simple-para id="fspara0010" view="all">Ras1 and Ras2 homology, expression and protein localization.</ce:simple-para><ce:simple-para id="fspara0015" view="all">(A) Protein sequence of Drosophila Ras1 and Ras2 aligned with their human orthologous H-, N- and K-Ras variant B (Ras1) and R-Ras, TC21 and M-Ras (Ras2) using the Praline Multiple Sequence Alignment Program. In red (Ras1) and blue (Ras2) are shaded identical amino acids. GTP Binding domains are indicated by green boxes (G1, amino</ce:simple-para><ce:simple-para id="fspara0020" view="all">acids 10&#x2013;18; G2, amino acids 57&#x2013;63; G3, amino acids 116&#x2013;119 and G4 amino acids 143&#x2013;146); effector binding domain (amino acids 32&#x2013;40) is in red box; switch I (amino acids 25&#x2013;40) and switch II (amino acids 60&#x2013;76), corresponding GAP and GEF binding domains, are indicated by white arrows. The CAAX motif is indicated in a blue box. (B&#x2013;C) Expression in the wing disc of anti-sense (B) and sense (C) probes for <ce:italic>Ras1</ce:italic>. (D&#x2013;E) Expression in the wing disc of anti-sense (B) and sense (C) probes for <ce:italic>Ras2</ce:italic>. (F&#x2013;I) Expression of Flag (red) and Topro (blue) in the ring gland of <ce:italic>phm-Gal4/UAS-Flag-Ras1</ce:italic> (F), <ce:italic>phm-Gal4/UAS-Flag-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup> (G), <ce:italic>phm-Gal4/UAS-Flag-Ras2</ce:italic> (H) and <ce:italic>phm-Gal4/UAS-Flag-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (I). Scale bars represent 100 pixels for <ce:italic>in situ</ce:italic> staining, and 50&#160;&#x200b;&#x03bc;m for confocal images of ring glands.</ce:simple-para></ce:caption><ce:alt-text id="alttext0020" role="short">Fig.&#160;1</ce:alt-text><ce:link locator="gr1" xlink:href="pii:S0012160620300609/gr1" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure><ce:figure id="fig2"><ce:label>Fig.&#160;2</ce:label><ce:caption id="cap0025"><ce:simple-para id="fspara0025" view="all">Adult wing phenotype of activated Ras1 and Ras2 overexpression.</ce:simple-para><ce:simple-para id="fspara0030" view="all">(A&#x2013;F) Adult female wings of the following genotype: <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP</ce:italic>/+ (control wing; A), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup> (B), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (C), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup><ce:italic>/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (D), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-Ras1-RNAi/UAS-GFP</ce:italic> (E) and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-Ras1-RNAi/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (F). Black arrows in C, D and F indicate extruded wing tissue.</ce:simple-para></ce:caption><ce:alt-text id="alttext0025" role="short">Fig.&#160;2</ce:alt-text><ce:link locator="gr2" xlink:href="pii:S0012160620300609/gr2" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure><ce:figure id="fig3"><ce:label>Fig.&#160;3</ce:label><ce:caption id="cap0030"><ce:simple-para id="fspara0035" view="all">Molecular and phenotypic characterization of <ce:italic>Ras2</ce:italic> mutant alleles.</ce:simple-para><ce:simple-para id="fspara0040" view="all">(A) Protein sequence (showing functional domains) of the predicted peptides encoded by mutant <ce:italic>Ras2</ce:italic> coding regions generated by CRISPR-Cas9, along with wild type Ras2 and human TC21 protein sequences. (B&#x2013;D) Control wing (B) and homozygous <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> (C) and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> (D) mutant wings. (E&#x2013;G) Wing size (E), cell size (F) and estimated number of cells (G) of control, <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> mutant wings (p&#160;&#x200b;=&#160;&#x200b;0,001 for Ras2<ce:sup loc="post">3</ce:sup> and p&#160;&#x200b;=&#160;&#x200b;8,9E-05 for Ras2<ce:sup loc="post">17</ce:sup> in E, p&#160;&#x200b;=&#160;&#x200b;0,572 for Ras2<ce:sup loc="post">3</ce:sup> and p&#160;&#x200b;=&#160;&#x200b;0,068 for Ras2<ce:sup loc="post">17</ce:sup> in F, and p&#160;&#x200b;=&#160;&#x200b;0,008 for Ras2<ce:sup loc="post">3</ce:sup> and p&#160;&#x200b;=&#160;&#x200b;9,9E-05 for Ras2<ce:sup loc="post">17</ce:sup> in G, using T-test; n&#160;&#x200b;=&#160;&#x200b;10 in all cases). (H) Pupation time measured as the percentage of pupae at a given time for control (blue), <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> (red) and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> (green) flies. (I) Survival measured as percentage of living flies after a given time after eclosion for control (blue), <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> (red, p&#160;&#x200b;&lt;&#160;&#x200b;0.0001) and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> (green, p&#160;&#x200b;&lt;&#160;&#x200b;0.0001) flies. Median survival was 45, 50 and 60 days, respectively. Statistical analyses of survival curves were carried out using both Log-rank (Mantel-Cox) and Gehan-Breslow-Wilcoxon tests: differences between control and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> curves were not statistically significant (p&#160;&#x200b;=&#160;&#x200b;0,13 and p&#160;&#x200b;=&#160;&#x200b;0,09, depending on the test), whereas the <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> survival curve was significantly different from the control (p&#160;&#x200b;&lt;&#160;&#x200b;0,0001 in both tests). We consider that there is a significant difference when the <ce:italic>p-value</ce:italic> is lower than 0.001 (***), 0.01 (**) or 0.05 (*).</ce:simple-para></ce:caption><ce:alt-text id="alttext0030" role="short">Fig.&#160;3</ce:alt-text><ce:link locator="gr3" xlink:href="pii:S0012160620300609/gr3" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure><ce:figure id="fig4"><ce:label>Fig.&#160;4</ce:label><ce:caption id="cap0035"><ce:simple-para id="fspara0045" view="all">Genetic interaction between a <ce:italic>Ras2</ce:italic> null allele and <ce:italic>Ras1</ce:italic> knock-down conditions.</ce:simple-para><ce:simple-para id="fspara0050" view="all">(A&#x2013;B) Female mutant wings of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras1-RNAi</ce:italic> (sal/Ras1-i; A) and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup><ce:italic>UAS-Ras1-RNAi/Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> (sal/Ras1-i; Ras2<ce:sup loc="post">3</ce:sup>; B). Inset to the bottom right correspond to higher magnification details (40&#215;) of a dorsal and distal wing region located between the veins L3 and L4. (C) sal-Gal4 domain size of control, <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup><ce:italic>, sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; UAS-Ras1-RNAi/</ce:italic>&#160;&#x200b;+&#160;&#x200b;and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; UAS-Ras1-RNAi Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup><ce:italic>/Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> mutant wings (p&#160;&#x200b;=&#160;&#x200b;0,0084 for control versus <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup>, n&#160;&#x200b;=&#160;&#x200b;10 and 6% of area reduction; and p&#160;&#x200b;=&#160;&#x200b;0,001 for <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GPP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>;UAS-Ras1-RNAi/</ce:italic>&#160;&#x200b;+&#160;&#x200b;(n&#160;&#x200b;=&#160;&#x200b;8) versus mutant <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; UAS-Ras1-RNAi Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup><ce:italic>/Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> background (n&#160;&#x200b;=&#160;&#x200b;11) with an 11% reduction in the size of the sal domain. (D&#x2013;E) Cell size within the sal-Gal4 expression domain (p&#160;&#x200b;=&#160;&#x200b;7,3E-05) (D) and estimated number of cells (p&#160;&#x200b;=&#160;&#x200b;0,0018) present in this domain in <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras1-RNAi</ce:italic> (n&#160;&#x200b;=&#160;&#x200b;12) and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup><ce:italic>UAS-Ras1-RNAi/Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> mutant wings (n&#160;&#x200b;=&#160;&#x200b;11). We consider that there is a significant difference when the <ce:italic>p-value</ce:italic> is lower than 0.001 (***), 0.01 (**) or 0.05 (*).</ce:simple-para></ce:caption><ce:alt-text id="alttext0035" role="short">Fig.&#160;4</ce:alt-text><ce:link locator="gr4" xlink:href="pii:S0012160620300609/gr4" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure><ce:figure id="fig5"><ce:label>Fig.&#160;5</ce:label><ce:caption id="cap0040"><ce:simple-para id="fspara0055" view="all">Functional relationship of Ras proteins with the InR and EGFR signalling pathways.</ce:simple-para><ce:simple-para id="fspara0060" view="all">(A-A&#x2032;) Accumulation of dP-Erk (red in A; white in A&#x2032;) and GFP (green in A) in control <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;wing pouch. (B&#x2013;B&#x2032;) Accumulation of dP-Erk (red in B; white in B&#x2032;) and GFP (green in B) in <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-EGF</ce:italic>R* wing pouch. (C&#x2013;C&#x2032;) Accumulation of dP-Erk (red in C; white in C&#x2032;) and GFP (green in C) in <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-rolled-RNAi</ce:italic> wing pouch. (D-D&#x2032;) Expression of GFP (green) and dP-Erk (red in D and white in D&#x2032;) in <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup> wing discs. (E-E&#x2032;) Expression of GFP (green in E) and dP-Erk (red in E and white in E&#x2032;) in <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> wing discs. (F) Representative Western blot showing total Akt, P-Akt, total Erk, dP-Erk and gamma-tubulin (loading control) in protein extracts from <ce:italic>wt</ce:italic>, <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> larvae. (G) Quantifications of dP-Erk (p&#160;&#x200b;=&#160;&#x200b;0.0907 for <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup>, and p&#160;&#x200b;=&#160;&#x200b;0.2776 for <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup>, using T-test statistic analysis). The levels of P-Akt and dP-Erk were normalized to total Akt and total Erk, respectively. (H) Quantifications of P-Akt (p&#160;&#x200b;=&#160;&#x200b;0.0893 for <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup>, and p&#160;&#x200b;=&#160;&#x200b;0.0021 for <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup>, using T-test statistical analysis. Column bar graphs show mean with standard deviation. We consider that there is a significant difference when the <ce:italic>p-value</ce:italic> is lower than 0.001 (***), 0.01 (**) or 0.05 (*).</ce:simple-para></ce:caption><ce:alt-text id="alttext0040" role="short">Fig.&#160;5</ce:alt-text><ce:link locator="gr5" xlink:href="pii:S0012160620300609/gr5" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure><ce:figure id="fig6"><ce:label>Fig.&#160;6</ce:label><ce:caption id="cap0045"><ce:simple-para id="fspara0065" view="all">(A-A&#x2032;) Accumulation of P-Akt (red in A and white in A&#x2032;) and GFP (green in A) in control wing discs of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;genotype. (B&#x2013;B&#x2032;) Accumulation of P-Akt (red in B and white in B&#x2032;) and GFP (green in B) in wing discs of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup> genotype. (C&#x2013;C&#x2032;) Accumulation of P-Akt (red in H and white in H&#x2032;) and GFP (green in H) in wing discs of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> genotype. (D-D&#x2019;&#180;&#180;) Accumulation of P-Akt (red in D and white in D&#x2033;) and GFP (green in D and white in D&#x2019;) in wing discs of <ce:italic>UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup><ce:italic>/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; hh-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;genotype. The nuclei are labelled with ToPro (blue in D and white in D&#x2019;&#180;&#180;). (E-E&#180;&#180;&#180;) Accumulation of P-Akt (red in E and white in E&#x2033;) and GFP (green in E and white in E&#x2019;) in wing discs of <ce:italic>UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup><ce:italic>/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; hh-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;genotype. The nuclei are labelled with ToPro (blue in E and white in E&#x2019;&#180;&#180;). (F-F&#x2032;) Accumulation of P-Akt (red in F and white in F&#x2032;) and GFP (green in F) in wing discs of. <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-InR*</ce:italic> genotype. (G-G&#x2032;) Accumulation of P-Akt (red in G and white in G&#x2032;) and GFP (green in G) in <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-PTEN-RNAi</ce:italic> wing discs. (H&#x2013;H&#x2032;) Accumulation of P-Akt (red in H and white in H&#x2032;) and GFP (green in H) in <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Akt-RNAi</ce:italic> wing discs. Scale bars represent 50&#160;&#x200b;&#x03bc;m. (I) Quantification of relative P-Akt intensity levels between the central region of the wing blade (<ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4</ce:italic> domain of expression) and the anterior lateral region in wing discs of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;(control); <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup><ce:italic>(</ce:italic>sal&#160;&#x200b;&gt;&#160;&#x200b;Ras1<ce:sup loc="post">V12</ce:sup><ce:italic>); sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (sal&#160;&#x200b;&gt;&#160;&#x200b;Ras2<ce:sup loc="post">V14</ce:sup><ce:italic>); sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-InR* (</ce:italic>sal&#160;&#x200b;&gt;&#160;&#x200b;InR<ce:italic>*, p-value&#160;&#x200b;=&#160;&#x200b;2,9E-06); sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-PTEN-RNAi (sal&#160;&#x200b;&gt;&#160;&#x200b;PTEN-I; p-value&#160;&#x200b;=&#160;&#x200b;0.0016) and sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Akt-RNAi (sal&#160;&#x200b;&gt;&#160;&#x200b;Akt-1; p-value&#160;&#x200b;=&#160;&#x200b;3,4E-10)</ce:italic>. (I) Quantification of relative P-Akt intensity levels between the posterior and anterior regions of the wing blade in wing discs of <ce:italic>hh-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;(control), <ce:italic>UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup><ce:italic>/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; hh-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;(hh&#160;&#x200b;&gt;&#160;&#x200b;Ras1<ce:sup loc="post">V12</ce:sup>, p&#160;&#x200b;&lt;&#160;&#x200b;0,0001) and <ce:italic>UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup><ce:italic>/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; hh-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;(hh&#160;&#x200b;&gt;&#160;&#x200b;Ras2<ce:sup loc="post">V14</ce:sup>, p&#160;&#x200b;&lt;&#160;&#x200b;0,0001) genotypes. Scale bars represent 50&#160;&#x200b;&#x03bc;m. We consider that there is a significant difference when the <ce:italic>p-value</ce:italic> is lower than 0.001 (***), 0.01 (**) or 0.05 (*).</ce:simple-para></ce:caption><ce:alt-text id="alttext0045" role="short">Fig.&#160;6</ce:alt-text><ce:link locator="gr6" xlink:href="pii:S0012160620300609/gr6" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure><ce:figure id="fig7"><ce:label>Fig.&#160;7</ce:label><ce:caption id="cap0050"><ce:simple-para id="fspara0070" view="all">Wing phenotypes and expression of dP-Erk and P-Akt in wing discs expressing activated Ras1 and Ras2 and other mutations in the EGFR and InR pathways.</ce:simple-para><ce:simple-para id="fspara0075" view="all">(A&#x2013;C) Control wing (A), <ce:italic>en-Gal4/UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup> (B) and <ce:italic>en-Gal4/UAS-InR</ce:italic>* (C). Expression of InR<ce:sup loc="post">DN</ce:sup> in the posterior compartment (<ce:italic>en-Gal4/UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup>) causes a reduction in its size relative to the anterior one (B), whereas the posterior expression of activated InR (<ce:italic>en-Gal4/UAS-InR</ce:italic>*) generates a larger than normal posterior compartment (C). (D&#x2013;G) Expression of P-Akt (red) in the wing blade region of third instar wing discs in control larvae (D) and in larvae of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup> (E), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (F) and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS- InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup> (G). Loss of InR activity reduces the accumulation of P-Akt, and only Ras2<ce:sup loc="post">V14</ce:sup> is able to partially rescue the loss of P-Akt. Scale bars represent 50&#160;&#x200b;&#x03bc;m. (H&#x2013;J) Genetic combinations between InR<ce:sup loc="post">DN</ce:sup> and activated Ras1. Control <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup> (H), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup><ce:italic>/UAS-GFP</ce:italic> (I) and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup><ce:italic>/UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup> (J) combinations. (K&#x2013;M) Genetic combinations between InR<ce:sup loc="post">DN</ce:sup> and activated Ras2. <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;(K) and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (L) control wings, and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>v14</ce:italic></ce:sup> (M) combination. (N&#x2013;P) Genetic combinations between loss of <ce:italic>Dp110</ce:italic> (<ce:italic>UAS-dp110-RNAi</ce:italic>) expression and activated Ras proteins. Control <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-dp110-RNAi</ce:italic> (N), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup>/<ce:italic>UAS-dp110-RNAi</ce:italic> (O), and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup>/<ce:italic>UAS-dp110-RNAi</ce:italic> (P) wings. (Q&#x2013;T) Expression of dP-Erk (red) in the wing blade region of third instar wing discs in control larvae (Q) and in larvae of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-EGFR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup> (R), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-EGFR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (S) and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-EGFR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup> (T). Loss of EGFR activity reduces the accumulation of dP-Erk, and both Ras2<ce:sup loc="post">V14</ce:sup> and Ras1<ce:sup loc="post">V12</ce:sup> are able to rescue the loss of dP-Erk. Scale bars represent 50&#160;&#x200b;&#x03bc;m. (U&#x2013;W) Rescue of the lack of vein phenotype caused by loss of EGFR function. Control <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-EGFR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/</ce:italic>UAS-GFP (U), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-EGFR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup> (V) and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS- EGFR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (W).</ce:simple-para></ce:caption><ce:alt-text id="alttext0050" role="short">Fig.&#160;7</ce:alt-text><ce:link locator="gr7" xlink:href="pii:S0012160620300609/gr7" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure><ce:figure id="fig8"><ce:label>Fig.&#160;8</ce:label><ce:caption id="cap0055"><ce:simple-para id="fspara0080" view="all">Subcellular localization of Ras proteins and molecular interactions between Ras2 with PI3K and Raf.</ce:simple-para><ce:simple-para id="fspara0085" view="all">(A-H&#x2033;) Localization of tagged Ras2 (A, B&#x2013;B&#x2033;), Ras2<ce:sup loc="post">V14</ce:sup> (C, D-D&#x2033;), Raf (E, F&#x2013;F&#x2033;) and Dp110 proteins (G, H&#x2013;H&#x2033;) in late third instar wing disc of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-FLAG-Ras2</ce:italic>, <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-FLAG-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup>, <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Raf-Myc</ce:italic> and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Dp110-Myc</ce:italic> genotypes. In B, D, F and H are shown sagittal sections through the disc (indicated by white lines in A, C, E and G), with the red channel (Flag and Myc, middle) and Topro in white (lower). Scale bars represent 50&#160;&#x200b;&#x03bc;m. (I) Pulldowns assays performed with <ce:italic>in vitro</ce:italic> translated Dp100 or Raf [<ce:sup loc="post">35</ce:sup>S]-labelled protein and purified GST-Ras2 or GST-Ras<ce:sup loc="post">V14</ce:sup> proteins. (J) Embryos expressing tagged versions of Myc-Dp110, Flag-Ras2 or both in the absence or presence of activated InR where lysated and immunoprecipitated with anti-Flag antibody (M2) coupled to agarose beads and analysed by western-blot. A blot representative of at least 3 independent experiments is shown.</ce:simple-para></ce:caption><ce:alt-text id="alttext0055" role="short">Fig.&#160;8</ce:alt-text><ce:link locator="gr8" xlink:href="pii:S0012160620300609/gr8" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure></ce:floats><ja:head><ce:dochead id="dhead0010"><ce:textfn>Original research article</ce:textfn></ce:dochead><ce:title id="title0010">Ras2, the TC21/R-Ras2 Drosophila homologue, contributes to insulin signalling but is not required for organism viability</ce:title><ce:author-group id="augrp0010"><ce:author id="au1" author-id="S0012160620300609-afd9936ad17d32f1eda310a0a06be175"><ce:given-name>Patricia</ce:given-name><ce:surname>Vega-Cuesta</ce:surname><ce:cross-ref id="crosref0010" refid="fn4"><ce:sup loc="post">4</ce:sup></ce:cross-ref></ce:author><ce:author id="au2" author-id="S0012160620300609-3ac44893560aea6e5ceec32974570ac5"><ce:given-name>Ana</ce:given-name><ce:surname>Ruiz-G&#243;mez</ce:surname><ce:cross-ref id="crosref0015" refid="fn4"><ce:sup loc="post">4</ce:sup></ce:cross-ref></ce:author><ce:author id="au3" author-id="S0012160620300609-06e50e0954f9c098237e790f4e0b52da"><ce:given-name>Cristina</ce:given-name><ce:surname>Molnar</ce:surname><ce:cross-ref id="crosref0020" refid="fn1"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au4" author-id="S0012160620300609-7666025a659ae4b84c7d6afdae243ffb"><ce:given-name>Maria F.</ce:given-name><ce:surname>Organista</ce:surname></ce:author><ce:author id="au5" author-id="S0012160620300609-cbf876f1a808231369dcaa25a75a6437"><ce:given-name>Mart&#237;n</ce:given-name><ce:surname>Resnik-Docampo</ce:surname><ce:cross-ref id="crosref0025" refid="fn2"><ce:sup loc="post">2</ce:sup></ce:cross-ref></ce:author><ce:author id="au6" orcid="0000-0002-3563-4789" author-id="S0012160620300609-1c91d002f2492dab58eaf74067133025"><ce:given-name>Julia</ce:given-name><ce:surname>Falo-Sanjuan</ce:surname><ce:cross-ref id="crosref0030" refid="fn3"><ce:sup loc="post">3</ce:sup></ce:cross-ref></ce:author><ce:author id="au7" author-id="S0012160620300609-71ef62b7c4b045ba47c976100a8229f4"><ce:given-name>Ana</ce:given-name><ce:surname>L&#243;pez-Varea</ce:surname></ce:author><ce:author id="au8" author-id="S0012160620300609-882d7ff5f8b383dd774d9e93a72f2e38"><ce:given-name>Jose F.</ce:given-name><ce:surname>de Celis</ce:surname><ce:cross-ref id="crosref0035" refid="cor1"><ce:sup loc="post">&#x2217;</ce:sup></ce:cross-ref><ce:e-address id="eadd0010" type="email" xlink:href="mailto:jfdecelis@cbm.csic.es">jfdecelis@cbm.csic.es</ce:e-address></ce:author><ce:affiliation id="aff1" affiliation-id="S0012160620300609-2957e8f3e044ca1f0fb68aefd84abdfd"><ce:textfn>Centro de Biolog&#237;a Molecular &#x201c;Severo Ochoa&#x201d;, CSIC and Universidad Aut&#243;noma de Madrid, Madrid, 28049, Spain</ce:textfn><sa:affiliation><sa:organization>Centro de Biolog&#237;a Molecular &#x201c;Severo Ochoa&#x201d;</sa:organization><sa:organization>CSIC and Universidad Aut&#243;noma de Madrid</sa:organization><sa:city>Madrid</sa:city><sa:postal-code>28049</sa:postal-code><sa:country>Spain</sa:country></sa:affiliation><ce:source-text id="srct0010">Centro de Biologia Molecular &#x201c;Severo Ochoa&#x201d;, CSIC and Universidad Autonoma de Madrid, Madrid, 28049, Spain</ce:source-text></ce:affiliation><ce:correspondence id="cor1"><ce:label>&#x2217;</ce:label><ce:text>Corresponding author.</ce:text></ce:correspondence><ce:footnote id="fn1"><ce:label>1</ce:label><ce:note-para id="ntpara0010" view="all">Present address: Institute for Research in Biomedicine-Barcelona, Barcelona, Spain.</ce:note-para></ce:footnote><ce:footnote id="fn2"><ce:label>2</ce:label><ce:note-para id="ntpara0015" view="all">Present address: University of California, Los Angeles. Department of Molecular, Cell, and Developmental Biology. Los Angeles, USA.</ce:note-para></ce:footnote><ce:footnote id="fn3"><ce:label>3</ce:label><ce:note-para id="ntpara0020" view="all">Present address: Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge. UK.</ce:note-para></ce:footnote><ce:footnote id="fn4"><ce:label>4</ce:label><ce:note-para id="ntpara0025" view="all">The first two authors contributed equally to this work.</ce:note-para></ce:footnote></ce:author-group><ce:date-received day="31" month="10" year="2019"/><ce:date-revised day="9" month="2" year="2020"/><ce:date-accepted day="10" month="2" year="2020"/><ce:abstract class="author" id="abs0010" xml:lang="en" view="all"><ce:section-title id="sectitle0010">Abstract</ce:section-title><ce:abstract-sec id="abssec0010" view="all"><ce:simple-para id="abspara0010" view="all">Ras1 (<ce:italic>Ras85D</ce:italic>) and <ce:italic>Ras2</ce:italic> (<ce:italic>Ras64B</ce:italic>) are the Drosophila orthologs of human <ce:italic>H-Ras/N-Ras/K-Ras</ce:italic> and <ce:italic>R-Ras1-3</ce:italic> genes, respectively. The function of Ras1 has been thoroughly characterised during Drosophila embryonic and imaginal development, and it is associated with coupling activated trans-membrane receptors with tyrosine kinase activity to their downstream effectors. In this capacity, Ras1 binds and is required for the activation of Raf. Ras1 can also interact with PI3K, and it is needed to achieve maximal levels of PI3K signalling in specific cellular settings. In contrast, the function of the unique Drosophila R-Ras member (Ras2/Ras64B), which is more closely related to vertebrate R-Ras2/TC21, has been only studied through the use of constitutively activated forms of the protein. This pioneering work identified a variety of phenotypes that were related to those displayed by Ras1, suggesting that Ras1 and Ras2 might have overlapping activities. Here we find that Ras2 can interact with PI3K and Raf and activate their downstream effectors Akt and Erk. However, and in contrast to mutants in <ce:italic>Ras1</ce:italic>, which are lethal, null alleles of <ce:italic>Ras2</ce:italic> are viable in homozygosis and only show a phenotype of reduced wing size and extended life span that might be related to reduced Insulin receptor signalling.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="author-highlights" id="abs0015" xml:lang="en" view="all"><ce:section-title id="sectitle0015">Highlights</ce:section-title><ce:abstract-sec id="abssec0015" view="all"><ce:simple-para id="abspara0015" view="all"><ce:list id="ulist0010"><ce:list-item id="u0010"><ce:label>&#x2022;</ce:label><ce:para id="p0010" view="all">We generated mutations in the Drosophila <ce:italic>Ras2</ce:italic> gene, orthologous to human <ce:italic>RRas1</ce:italic>, <ce:italic>RRas2/TC21</ce:italic> and <ce:italic>RRas3.</ce:italic></ce:para></ce:list-item><ce:list-item id="u0015"><ce:label>&#x2022;</ce:label><ce:para id="p0015" view="all">Loss of <ce:italic>Ras2</ce:italic> function does not compromise organism viability, but cause reduced wing size and expanded life span.</ce:para></ce:list-item><ce:list-item id="u0020"><ce:label>&#x2022;</ce:label><ce:para id="p0020" view="all">Ras2 interact with the InR transducer PI3K.</ce:para></ce:list-item><ce:list-item id="u0025"><ce:label>&#x2022;</ce:label><ce:para id="p0025" view="all">Activated and overexpressed Ras2 can supply for Ras1 function.</ce:para></ce:list-item><ce:list-item id="u0030"><ce:label>&#x2022;</ce:label><ce:para id="p0030" view="all">Ras2 participates in one of several complementary mechanisms downstream to InR.</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords class="keyword" id="kwrds0010" xml:lang="en" view="all"><ce:section-title id="sectitle0020">Keywords</ce:section-title><ce:keyword id="kwrd0010"><ce:text>Ras</ce:text></ce:keyword><ce:keyword id="kwrd0015"><ce:text>Akt</ce:text></ce:keyword><ce:keyword id="kwrd0020"><ce:text>Erk</ce:text></ce:keyword><ce:keyword id="kwrd0025"><ce:text>InR signalling</ce:text></ce:keyword><ce:keyword id="kwrd0030"><ce:text>Wing disc</ce:text></ce:keyword></ce:keywords></ja:head><ja:body view="all"><ce:sections><ce:section id="sec1" role="introduction" view="all"><ce:label>1</ce:label><ce:section-title id="sectitle0025">Introduction</ce:section-title><ce:para id="p0035" view="all">Signalling by tyrosine kinase transmembrane receptors involves the assembling of protein complexes in their cytoplasmic tails that connect the receptor with downstream effectors (<ce:cross-ref id="crosref0040" refid="bib41">Simanshu et&#160;al., 2017</ce:cross-ref>). Among the most prominent components of these complexes are guanine nucleotide-binding proteins of the Ras superfamily, which can cycle between active GTP- and inactive GDP-bound states. The cycling of typical Ras superfamily members is controlled by proteins that promote the exchange of GDP for GTP (<ce:underline>G</ce:underline>uanine nucleotide <ce:underline>E</ce:underline>xchange <ce:underline>F</ce:underline>actors or GEFs), and by proteins that enhance the Ras GTPase activity (<ce:underline>G</ce:underline>TPase <ce:underline>A</ce:underline>ctivating <ce:underline>P</ce:underline>roteins or GAPs) (<ce:cross-ref id="crosref0045" refid="bib1">Bernards, 2003</ce:cross-ref>). Other adaptor proteins interact with receptor phospho-tyrosines, and bring GEFs to the cell membrane, where they trigger Ras activation and allow Ras-GTP to interact with cytoplasmic targets (<ce:cross-ref id="crosref0050" refid="bib1">Bernards, 2003</ce:cross-ref>). Classical Ras subfamily proteins in humans include H-Ras, N-Ras and K-Ras. These proteins present a 90&#x2013;100% conserved amino-terminal catalytic domain of 165 amino acids and a less conserved carboxy-terminal stretch of 25 amino acids, named hypervariable region (HVR) that is important for posttranscriptional modifications and subcellular localization (<ce:cross-ref id="crosref0055" refid="bib41">Simanshu et&#160;al., 2017</ce:cross-ref>). Direct effectors of Ras-GTP are the Raf kinases, leading to activation of the MAP kinase cascade, and phosphatidylinositol-3 kinase (PI3K), which contributes to the stimulation of Akt (<ce:cross-ref id="crosref0060" refid="bib41">Simanshu et&#160;al., 2017</ce:cross-ref>). Interestingly, and despite the overall sequence conservation present between classic Ras members, K-Ras is the more potent activator of Raf-1, and H-Ras the more potent activator of PI3K (<ce:cross-ref id="crosref0065" refid="bib45">Voice et&#160;al., 1999</ce:cross-ref>). Furthermore <ce:italic>K-Ras</ce:italic>-knockout mice are embryonic lethal, whereas <ce:italic>H-Ras</ce:italic>, <ce:italic>N-Ras</ce:italic> and <ce:italic>H-Ras&#x2013;N-Ras</ce:italic> double knockouts survive normally (<ce:cross-ref id="crosref0070" refid="bib11">Esteban et&#160;al., 2001</ce:cross-ref>; <ce:cross-ref id="crosref0075" refid="bib21">Koera et&#160;al., 1997</ce:cross-ref>). Some of the differences in the behaviour of Ras genes rely on the regulation of each gene expression, because, for example, H-Ras expression from the <ce:italic>K-Ras</ce:italic> locus is able to rescue the lethality of <ce:italic>K-Ras</ce:italic> knockout mice (<ce:cross-ref id="crosref0080" refid="bib31">Potenza et&#160;al., 2005</ce:cross-ref>).</ce:para><ce:para id="p0040" view="all">The Ras-related protein subfamily (R-Ras) includes R-Ras1, R-Ras2 (TC21) and R-Ras3 (M-Ras). These proteins have similar size and display overall sequence conservation (63%) with classical Ras (<ce:cross-ref id="crosref0085" refid="bib13">Graham et&#160;al., 1994</ce:cross-ref>). They can also activate the same downstream effectors with different efficiency. R-Ras2/TC21, in addition, displays a transforming activity similar to that of K-Ras (<ce:cross-ref id="crosref0090" refid="bib13">Graham et&#160;al., 1994</ce:cross-ref>), and stimulates the activation of mitogen-activated protein kinases, PI3K, Ral signalling and transcription from Ras-responsive promoters (<ce:cross-ref id="crosref0095" refid="bib26">Movilla et&#160;al., 1999</ce:cross-ref>; <ce:cross-ref id="crosref0100" refid="bib27">Ohba et&#160;al., 2000</ce:cross-ref>; <ce:cross-ref id="crosref0105" refid="bib35">Rosario et&#160;al., 1999</ce:cross-ref>, <ce:cross-ref id="crosref0110" refid="bib36">2001</ce:cross-ref>). R-Ras2/TC21 is particularly required <ce:italic>in vivo</ce:italic> for the survival of mature T- and B-cells populations, and interacts with different subunits of the T-cell and B-cell antigen receptors (<ce:cross-ref id="crosref0115" refid="bib9">Delgado et&#160;al., 2009</ce:cross-ref>). In these cellular settings, R-Ras2/TC21 contributes to the maintenance of housekeeping levels of PI3K activity (<ce:cross-ref id="crosref0120" refid="bib9">Delgado et&#160;al., 2009</ce:cross-ref>; <ce:cross-ref id="crosref0125" refid="bib23">Larive et&#160;al., 2012</ce:cross-ref>). Therefore, R-Ras2/TC21 appears more specialized in the activation of the PI3K pathway rather than the Raf/ERK one (<ce:cross-ref id="crosref0130" refid="bib23">Larive et&#160;al., 2012</ce:cross-ref>). The distinction between classical Ras and R-Ras subfamilies is already present in insects. Thus, in <ce:italic>Drosophila melanogaster</ce:italic> there is one member of each subfamily: Ras1 (Ras85D) is related to classical Ras, whereas Ras2 (Ras64B) is more similar to R-Ras2/TC21. Ras1 plays a central role in the EGFR-Raf-Erk signalling cascade (<ce:cross-ref id="crosref0135" refid="bib10">Diaz-Benjumea and Hafen, 1994</ce:cross-ref>; <ce:cross-ref id="crosref0140" refid="bib42">Simon et&#160;al., 1991</ce:cross-ref>), but is also required in specific developmental contexts to promote maximal PI(3)K signalling (<ce:cross-ref id="crosref0145" refid="bib29">Orme et&#160;al., 2006</ce:cross-ref>).</ce:para><ce:para id="p0045" view="all">The analysis of Ras1 and Ras2 has relied to some extent on the use of activating mutations that render these proteins insensitive to GAPs. These mutations, G12V in Ras1 and G14V in Ras2, are strongly oncogenic in humans, and cause a variety of developmental effects during Drosophila embryonic and imaginal development (<ce:cross-ref id="crosref0150" refid="bib2">Bishop and Corces, 1988</ce:cross-ref>; <ce:cross-ref id="crosref0155" refid="bib34">Rajalingam et&#160;al., 2007</ce:cross-ref>). Further genetic analysis in this organism identified Ras1 requirements to regulate cell growth (<ce:cross-ref id="crosref0160" refid="bib16">Heumann et&#160;al., 2000</ce:cross-ref>; <ce:cross-ref id="crosref0165" refid="bib32">Prober and Edgar, 2000</ce:cross-ref>), the progression through the G1/S transition of the cell cycle (<ce:cross-ref id="crosref0170" refid="bib20">Johnston et&#160;al., 1999</ce:cross-ref>; <ce:cross-ref id="crosref0175" refid="bib33">Prober and Edgar, 2002</ce:cross-ref>; <ce:cross-ref id="crosref0180" refid="bib48">Weinkove et&#160;al., 1999</ce:cross-ref>) and cell fate and territorial specification (<ce:cross-ref id="crosref0185" refid="bib14">Guichard et&#160;al., 1999</ce:cross-ref>; <ce:cross-ref id="crosref0190" refid="bib42">Simon et&#160;al., 1991</ce:cross-ref>; <ce:cross-ref id="crosref0195" refid="bib46">Wang et&#160;al., 2000</ce:cross-ref>; <ce:cross-ref id="crosref0200" refid="bib49">Zecca and Struhl, 2002</ce:cross-ref>). These effects are mediated by Ras1 acting as a core component of the EGFR and other tyrosine kinase transmembrane receptors, ultimately stimulating the Raf/MEK/ERK signalling cascade. Less clear is the relationships between Ras1 and the Insulin receptor (InR) signalling pathway, which is required in imaginal cells for growth and acts activating the PI3K/Akt/Tor signalling cascade (<ce:cross-ref id="crosref0205" refid="bib24">Lizcano and Alessi, 2002</ce:cross-ref>; <ce:cross-ref id="crosref0210" refid="bib28">Oldham and Hafen, 2003</ce:cross-ref>). In imaginal discs, the epithelia that give rise to the adult structures of the fly, activated forms of Ras1 promote growth acting through the dPI3K pathway and dMyc (<ce:cross-ref id="crosref0215" refid="bib33">Prober and Edgar, 2002</ce:cross-ref>), in a similar manner as its vertebrate counterparts in mammalian cell cultures (<ce:cross-ref id="crosref0220" refid="bib30">Pacold et&#160;al., 2000</ce:cross-ref>; <ce:cross-ref id="crosref0225" refid="bib40">Sears et&#160;al., 2000</ce:cross-ref>). However, endogenous Ras1 is only required to maintain normal levels of dMyc (<ce:cross-ref id="crosref0230" refid="bib33">Prober and Edgar, 2002</ce:cross-ref>), and Ras mediated activation of PI3K is only essential during germ cell development and to acquire maximal levels of PI3K signalling (<ce:cross-ref id="crosref0235" refid="bib29">Orme et&#160;al., 2006</ce:cross-ref>). To date, no specific function has been assigned to Ras2, although its constitutive activation affects processes regulated by the EGFR pathway such as vein formation in the wing and cell fate specification in the eye (<ce:cross-ref id="crosref0240" refid="bib2">Bishop and Corces, 1988</ce:cross-ref>; <ce:cross-ref id="crosref0245" refid="bib44">Strutt and Strutt, 2003</ce:cross-ref>).</ce:para><ce:para id="p0050" view="all">Here we present a genetic and developmental analysis of <ce:italic>Ras2</ce:italic>, focussing on its requirements during the development of the wing imaginal disc. We have generated a collection of <ce:italic>Ras2</ce:italic> mutant alleles via CRISPR-Cas9 genome editing. We show that the function of <ce:italic>Ras2</ce:italic> is not required for organism viability, and that loss of <ce:italic>Ras2</ce:italic> has no significant effects on diphospho-ERK (dP-ERK) accumulation. Instead, <ce:italic>Ras2</ce:italic> mutants show reduced wing size, extended lifespan and reduced overall levels of P-Akt. We also show that Ras2 interacts with PI3K and to a lesser extent with Raf, suggesting that this protein has retained the ability to engage in similar interactions to Ras1, but that these interactions are not operative at physiological levels of expression or are masked by Ras1 function. In contrast, activated Ras2 can substitute for Ras1 function when overexpressed, further suggesting that overexpression and hyperactivation minimizes the functional divergence of Ras1 and Ras2 towards a common set of downstream effectors.</ce:para></ce:section><ce:section id="sec2" role="materials-methods" view="all"><ce:label>2</ce:label><ce:section-title id="sectitle0030">Materials and methods</ce:section-title><ce:section id="sec2.1" view="all"><ce:label>2.1</ce:label><ce:section-title id="sectitle0035">Genetic strains</ce:section-title><ce:para id="p0055" view="all">We used the following Gal4 lines <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 (</ce:italic><ce:cross-ref id="crosref0250" refid="bib7">Cruz et&#160;al., 2009</ce:cross-ref><ce:italic>)</ce:italic>, <ce:italic>nub-Gal4</ce:italic>, <ce:italic>hh-Gal4</ce:italic> and <ce:italic>en-Gal4</ce:italic> (<ce:cross-ref id="crosref0255" refid="bib4">Calleja et&#160;al., 1996</ce:cross-ref>). We also used from Bloomington stock center the stocks <ce:italic>phm-Gal4</ce:italic> (BL26159), <ce:italic>UAS-EGFR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup> (BL5634), UAS-EGFR<ce:sup loc="post">lTop</ce:sup> (BL 59843), <ce:italic>UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>act</ce:italic></ce:sup> (BL8263), <ce:italic>UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup> (BL8263) and <ce:italic>UAS-GFP</ce:italic>. We generated the following UAS lines: <ce:italic>UAS-Raf-Myc</ce:italic>, <ce:italic>UAS-Flag-Ras1</ce:italic>, <ce:italic>UAS-Flag-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup>, <ce:italic>UAS-Flag-Ras2, UAS-Flag-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> and <ce:italic>UAS-Dp110-Myc</ce:italic>. We also used the following RNA interference lines <ce:italic>UAS-Ras1-i</ce:italic> (28129), <ce:italic>UAS-PTEN-i</ce:italic> (35731) and <ce:italic>UAS-dp110-i</ce:italic> (107390) from the VDRC Stock Center. Flies were raised at 25&#160;&#x200b;&#176;C unless otherwise stated.</ce:para></ce:section><ce:section id="sec2.2" view="all"><ce:label>2.2</ce:label><ce:section-title id="sectitle0040">Wing and cell size measurements</ce:section-title><ce:para id="p0060" view="all">We analysed at least 10 wings from females of each genotype. Cell size was estimated from the number of trichomes in a dorsal region located between the L3 and L4 veins and wing size was measured in pixels, in both cases using the Analyse tool in Adobe Photoshop. Wing pictures were made with a Spot digital camera coupled to a Zeiss Axiplam microscope using the 5X and 40X objectives for wing sizes and trichome number, respectively. For all combinations analysed the pictures shown in the figures are representative of the resulting phenotype. Wing size measures of genetic combinations shown in <ce:cross-refs id="crosrefs0010" refid="fig2 fig7">Figs.&#160;2 and 7</ce:cross-refs> are presented in <ce:cross-ref id="crosref0260" refid="appsec1">Supple. Fig.&#160;1A and B</ce:cross-ref>. We only measured wings without major folding, as wing folding interferes with wing physical size.</ce:para></ce:section><ce:section id="sec2.3" view="all"><ce:label>2.3</ce:label><ce:section-title id="sectitle0045">P-Akt measurement in imaginal wing discs</ce:section-title><ce:para id="p0065" view="all">P-Akt levels of expression in wing discs from <ce:cross-refs id="crosrefs0015" refid="fig6 fig7">Figs.&#160;6 and 7</ce:cross-refs> were quantified using the tool &#x201c;Analyse&#x201d; from Phothoshop CS3 or ImageJ 1.48u (NIH, USA). We measured the &#x201c;average grey value&#x201d; in four pairs of squares located within and without the domain of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4</ce:italic> or <ce:italic>hh-Gal4</ce:italic> expression in the wing blade. We use at least ten independent discs.</ce:para></ce:section><ce:section id="sec2.4" view="all"><ce:label>2.4</ce:label><ce:section-title id="sectitle0050">Statistical analysis</ce:section-title><ce:para id="p0070" view="all">All numerical data including western blots, wing size, cell size and number, and intensity values were collected and processed in Microsoft Excel (<ce:italic>t</ce:italic>-test) and Prism 6 (survival curves comparisons) (Microsoft Inc.) and data were compared using a T-test. The statistical analyses of survival curves were carried out using Log-rank (Mantel-Cox) and Gehan-Breslow-Wilcoxon tests. Graphic representations were done with Prism 6. Box plots show the median and the first and third quartiles. Column bar graphs show mean with standard deviation. Unless otherwise indicated, we analysed at least 10 wing imaginal discs or mutant wings for each antibody staining and genetic combination. We consider that there is a significant difference when the <ce:italic>p-value</ce:italic> is lower than 0.001 (***), 0.01 (**) or 0.05 (*).</ce:para></ce:section><ce:section id="sec2.5" view="all"><ce:label>2.5</ce:label><ce:section-title id="sectitle0055">Generation of <ce:italic>Raf</ce:italic>, <ce:italic>PI3K</ce:italic>, <ce:italic>Ras1</ce:italic> and <ce:italic>Ras2</ce:italic> constructs</ce:section-title><ce:para id="p0075" view="all">The following constructs were generated: <ce:italic>UAS-Raf-Myc</ce:italic>, <ce:italic>UAS-dp110-Myc</ce:italic>, <ce:italic>UAS-Flag-Ras1</ce:italic>, <ce:italic>UAS-Flag-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup>, <ce:italic>UAS-Flag-Ras2</ce:italic>, <ce:italic>UAS-Flag-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup>, <ce:italic>GST-Ras2</ce:italic>, and <ce:italic>GST-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup>. Transgenic flies were generated by germ line injection in <ce:italic>y w</ce:italic> embryos following standard procedures (<ce:cross-ref id="crosref0265" refid="bib37">Rubin and Spradling, 1982</ce:cross-ref>). For each construct we generated at least three independent insertions. The coding sequence of each gene was obtained by PCR amplification of the following plasmids: EST GH03557 (DGCR) (<ce:italic>Raf</ce:italic>), EST SD05105 (DGCR) (<ce:italic>Dp110</ce:italic>), EST RE53955 (DGCR) (<ce:italic>Ras1</ce:italic>), and EST RE36103 (DGCR) (<ce:italic>Ras2</ce:italic>) (primers used are detailed in <ce:cross-ref id="crosref0270" refid="appsec1">Supple. Table&#160;1</ce:cross-ref>). Each PCR product was directionally cloned into pENTR/D-TOPO&#174; (Invitrogen). Mutant versions (Ras1<ce:sup loc="post">V12</ce:sup> and Ras2<ce:sup loc="post">V14</ce:sup>) were generated with the QuikChange site-directed mutagenesis kit (Stratagene) using as template Ras1-pENTR/D-TOPO&#174; or Ras2-pENTR/D-TOPO&#174; (see <ce:cross-ref id="crosref0275" refid="appsec1">Supple. Table&#160;1</ce:cross-ref>). The presence of each mutation was confirmed by sequencing the construct.</ce:para><ce:para id="p0080" view="all">For obtaining the C-terminal-Myc-tagged fusion proteins, we used the LR Clonase II&#174; reaction with Raf-pENTR/D-TOPO&#174; or PI3K-pENTR/D-TOPO&#174; and the pTWM (6XMyc-tag at the C-terminal) vector. For generating the N-terminal-Flag-tagged fusion proteins, we used the LR Clonase II&#174; reaction with Ras1-pENTR/D-TOPO&#174;, Ras1<ce:sup loc="post">V12</ce:sup>-pENTR/D-TOPO&#174;, Ras2-pENTR/D-TOPO&#174; or Ras2<ce:sup loc="post">V14</ce:sup>-pENTR/D-TOPO&#174; and the pTFW (3XFlag-tag at the N-terminal) vector. For expression <ce:italic>in vivo</ce:italic> in Gal4-expressing cells we followed the instructions from Invitrogen. The expression of these tagged proteins in the wing disc is shown in <ce:cross-ref id="crosref0280" refid="fig6">Fig.&#160;6</ce:cross-ref>A&#x2013;H.</ce:para><ce:para id="p0085" view="all">For generating GST-Ras2 and GST-Ras2<ce:sup loc="post">V14</ce:sup> constructs, Ras2-pENTR/TOPO&#174; or Ras2<ce:sup loc="post">V14</ce:sup>-pENTR/TOPO&#174; were used with the Clonase II&#174; and the pDEST&#x2122;15 vector (Thermo Fisher Scientific) for fusion-protein bacterial expression vector generation.</ce:para></ce:section><ce:section id="sec2.6" view="all"><ce:label>2.6</ce:label><ce:section-title id="sectitle0060">Immunohistochemistry and <ce:italic>in situ</ce:italic> hybridization</ce:section-title><ce:para id="p0090" view="all">We used the rabbit antibodies anti-diphosphorylated ERK1&amp;2 and anti-phospho Akt (Cell Signalling). We also used the mouse monoclonal antibodies anti-c-Myc 9E10 (Santa Cruz Biotechnology) and anti-FlagM2 (Sigma). Alexa Fluor secondary antibodies (used at 1:200 dilution) were from Invitrogen. Imaginal wing discs were dissected, fixed, and stained as described in [50]. Confocal images were taken in a LSM510 confocal microscope (Zeiss). <ce:italic>In situ</ce:italic> hybridization with <ce:italic>Ras2</ce:italic> and <ce:italic>Ras1</ce:italic> probes were carried out as described (<ce:cross-ref id="crosref0285" refid="bib8">de Celis, 1997</ce:cross-ref>). We used the cDNA <ce:italic>RE36103</ce:italic> as template to synthesize the <ce:italic>Ras2</ce:italic> probe. Z-sections were taken from 100 tangential planes of the wing blade region using the 63x objective. All images were processed with the program ImageJ 1.48u (NIH, USA) and Adobe Photoshop CS3.</ce:para></ce:section><ce:section id="sec2.7" view="all"><ce:label>2.7</ce:label><ce:section-title id="sectitle0065">Generation of <ce:italic>Ras2</ce:italic> mutants</ce:section-title><ce:para id="p0095" view="all">For CRISPR-Cas9-mediated <ce:italic>Ras2</ce:italic> mutagenesis we followed the strategy described in (<ce:cross-ref id="crosref0290" refid="bib22">Kondo and Ueda, 2013</ce:cross-ref>). Genomic Ras2 target sites were identified at (<ce:inter-ref id="intref0010" xlink:href="http://www.flyrnai.org/crispr2/" xlink:type="simple">http://www.flyrnai.org/crispr2/</ce:inter-ref>). Prior to final selection of <ce:italic>Ras2</ce:italic> guides, genomic PCR and sequencing of nos-Cas9 flies was performed to check for polymorphisms in the target regions. The 24bp oligonucleotides selected guide RNAs were 5&#x2032;CTTCCGTGTACGAGTCTTCAATGG3&#x2032; and 5&#x2032;AAACCCATTGAAGACTCGTACACG3&#x2019;. The presence of mutations was confirmed by sequencing PCR products obtained using genomic DNA from homozygous w; Ras2* flies as template. Stocks w; Ras2* that were no mutant for <ce:italic>Ras2</ce:italic> were used as control flies in lifespan, timing and western blots experiments.</ce:para></ce:section><ce:section id="sec2.8" view="all"><ce:label>2.8</ce:label><ce:section-title id="sectitle0070">Pull-down assays</ce:section-title><ce:para id="p0100" view="all">The fusion proteins GST-Ras2 and GST-Ras2<ce:sup loc="post">V14</ce:sup> and the GST protein (negative control) were expressed in <ce:italic>E.&#160;coli</ce:italic> BL21 strain. Following induction with 1&#160;&#x200b;mM IPTG, the GST-fusion proteins were purified by chromatography on Glutathione Sepharose 4B according to manufacturer&#x2019;s instructions (GE Healthcare). 1&#x2013;3&#160;&#x200b;mg of GST or GST fusion proteins were mixed with 25&#160;&#x200b;&#x03bc;l of 50% suspension of Glutathione Sepharose 4B for 1h at 4&#160;&#x200b;&#176;C in RIPA Buffer (40&#160;&#x200b;mM Tris-HCl pH7.5, 120&#160;&#x200b;mM NaCl, 1% NP40, 0,5% DOC, 0,1% SDS, 6 EDTA, 6&#160;&#x200b;mM EGTA, 10&#160;&#x200b;mM NaF, 1&#160;&#x200b;mM Na<ce:inf loc="post">3</ce:inf>VO<ce:inf loc="post">4</ce:inf> and protease inhibitors cocktail from Roche). The purity of purified proteins was made from Coomassie-brillant-blue staining of SDS-polyacrylamide gels and the concentration determined by the Lowry Protein Assay (BioRad DC Protein Assay). In <ce:italic>vitro</ce:italic> transcription and translation reactions (50&#160;&#x200b;&#x03bc;l) for Dp110 and Raf were carried out using an RRL system (TNTT7 Quick Coupled Transcription/Translation System; Promega, Madison, WI) with 1&#160;&#x200b;&#x03bc;g of pOT vector containing the cDNA <ce:italic>SD05105</ce:italic> (Dp110) or <ce:italic>GH03557</ce:italic> (Raf)) incubating for 90&#160;&#x200b;min&#160;&#x200b;at 30&#160;&#x200b;&#176;C with 25&#160;&#x200b;&#x03bc;Ci of [S<ce:sup loc="post">35</ce:sup>]-Met (Amersham). The pull-down assay was performed incubating over-night at 4&#160;&#x200b;&#176;C the same amount of GST or GST fusion proteins bound to Glutathione Sepharose 4B with <ce:italic>in vitro</ce:italic> translated Raf and Dp110. After centrifugation and washes the proteins were resolved by 6% SDS/PAGE and the existence of pull-down proteins was analysed by autoradiography. The pulldown experiments were repeated 3 times with the same results.</ce:para></ce:section><ce:section id="sec2.9" view="all"><ce:label>2.9</ce:label><ce:section-title id="sectitle0075">Western blot and immunoprecipitation</ce:section-title><ce:para id="p0105" view="all"><ce:italic>Embryos and larvae lysates:</ce:italic> Embryos were collected 24&#160;&#x200b;h after egg laying, washed in a 0.7% NaCl +0.04% Triton X-100 solution, de-corionated in 50% bleach and freezed at &#x2212;80&#160;&#x200b;&#176;C. Third instar larvae (10 larvae per replicate condition) were collected, washed in cold PBS and freezed at &#x2212;80&#160;&#x200b;&#176;C. Embryos were homogenised in immunoprecipitation (IP) buffer (40&#160;&#x200b;mM Tris-HCl, 120&#160;&#x200b;mM NaCl, 1% NP-40, 0.1% SDS, 0.5% DOC, 6&#160;&#x200b;mM EDTA, 6&#160;&#x200b;mM EGTA, 100&#160;&#x200b;&#x03bc;M PMSF and complete EDTA-free protease inhibitor cocktail tablet (Roche)) and larvae were homogenised with RIPA-CHAPSO buffer (40&#160;&#x200b;mM Tris-HCl, 120&#160;&#x200b;mM NaCl, 1% NP-40, 0.1% SDS, 0.5% DOC, 1% CHAPSO, 6&#160;&#x200b;mM EDTA, 6&#160;&#x200b;mM EGTA, 10&#160;&#x200b;mM NaF, 0,4&#160;&#x200b;mM Na&#x2083;VO&#x2084;&#183;2H&#x2082;O, 8&#160;&#x200b;&#x03bc;g/ml Aprotinin, 100&#160;&#x200b;&#x03bc;M PMSF and 2X HealtTM Protease and Phosphatase Inhibitor Cocktail (Thermo Scientific)). Both embryos and larvae were then incubated 2h at 4&#160;&#x200b;&#176;C. Lysates were clarified by centrifugation. Protein concentration in these lysates was determined by Lowry assay (BioRad DC Protein Assay).</ce:para><ce:para id="p0110" view="all"><ce:italic>Immunoprecipitation:</ce:italic> 50&#160;&#x200b;&#x03bc;g and 2&#160;&#x200b;mg of total protein from embryonic lysates were used to assess protein expression levels (input) and for the immunoprecipitation reactions, respectively. Immunoprecipitation reactions were performed by incubating the lysates with 1&#160;&#x200b;mg/ml BSA, 10% Glycerol and specific antibodies for Dp110-Myc (15&#160;&#x200b;&#x03bc;l of anti-Myc agarose, Santa Cruz Biotechnology), and for Flag-Ras2 (15&#160;&#x200b;&#x03bc;l of anti-FlagM2 agarose, Sigma) in RIPA Buffer at 4&#160;&#x200b;&#176;C for 12&#x2013;16h. The beads were washed three times with RIPA buffer and boiled in Laemmli sample buffer for 10&#160;&#x200b;min. The immunoprecipitation experiments for Ras2 and Dp110 were repeated 5 times.</ce:para><ce:para id="p0115" view="all"><ce:italic>Immunoblotting:</ce:italic> Embryo lysates or immunoprecipitated complexes (IP) and larval lysates (Western blot) were resolved by 7.5% SDS-PAGE and proteins were transferred to nitrocellulose membranes using a semi-dry blotting apparatus (BioRad). We used the following primary antibodies: anti-diphospho-ERK (Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP Rabbit mAb #4370 from Cell Signalling used 1:1000), anti-pan-ERK (p44/42 MAPK (Erk1/2) Antibody#9102 from Cell Signalling used 1:500), anti-phospho-Akt (Phospho-Drosophila Akt (Ser505) antibody #4054 from Cell Signalling used 1:1000), anti-pan-Akt (Akt (pan) (C67E7) Rabbit mAb #4691 from Cell Signalling used 1:500) and anti-gamma-tubulin (1:1000) (Sigma); Dp110-Myc protein was detected by incubating with anti-Myc monoclonal antibody (1:200) (c-Myc 9E10, Santa Cruz Biotechnology). Ras2-Flag proteins were detected by incubating with anti-Flag polyclonal antibody (1:1000) (Thermo Scientific). Immunoblots were developed using IR680 and 800 labelled antibodies (Li-Cor) with the Odyssey Infrared Imaging System (Li-Cor) and/or ECL&#x2122; peroxidase-labelled anti-mouse or anti-rabbit antibodies revealed with ECL Western Blotting Detection Reagents (GE Healthcare). Western blots for determining di-phospho-ERK and phosphor-Akt amount were repeated 5 times.</ce:para></ce:section><ce:section id="sec2.10" view="all"><ce:label>2.10</ce:label><ce:section-title id="sectitle0080">Lifespan experiments</ce:section-title><ce:para id="p0120" view="all">For lifespan experiments newly eclosed flies were collected and kept at a density of 15&#x2013;20 males per vial on standard conditions. Flies were transferred to new vials twice per week. Total flies used were n&#160;&#x200b;=&#160;&#x200b;96 for control flies (<ce:italic>w; Ras2</ce:italic><ce:sup loc="post"><ce:italic>+</ce:italic></ce:sup>), n&#160;&#x200b;=&#160;&#x200b;79 for <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> mutant and n&#160;&#x200b;=&#160;&#x200b;136 for <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> mutant (<ce:italic>w; Ras2</ce:italic><ce:sup loc="post"><ce:italic>mut</ce:italic></ce:sup>). Control flies for <ce:italic>Ras2</ce:italic> alleles were from a <ce:italic>w; Ras2</ce:italic><ce:sup loc="post"><ce:italic>+</ce:italic></ce:sup> strain obtained using the same crosses as the strains carrying mutations in <ce:italic>Ras2.</ce:italic></ce:para></ce:section><ce:section id="sec2.11" view="all"><ce:label>2.11</ce:label><ce:section-title id="sectitle0085">Developmental timing</ce:section-title><ce:para id="p0125" view="all">For calculating developmental timing we measured the time in days from egg laying to puparium formation. We used 3-days old flies (5 males and 10 females per vial) that were transferred daily to a new vial. The number of pupae was counted each 24&#160;&#x200b;h. At least 100 pupae were counted per genotype. All life span and developmental timing experiments were conducted at 25&#160;&#x200b;&#176;C in flies of the same genetic background. Control flies for Ras2 alleles was a <ce:italic>w; Ras2</ce:italic><ce:sup loc="post"><ce:italic>+</ce:italic></ce:sup> strain obtained using the same crosses as the strains carrying mutations in Ras2.</ce:para></ce:section></ce:section><ce:section id="sec3" role="results" view="all"><ce:label>3</ce:label><ce:section-title id="sectitle0090">Results</ce:section-title><ce:section id="sec3.1" view="all"><ce:label>3.1</ce:label><ce:section-title id="sectitle0095">Wing phenotypes of activating mutations in Ras1 and Ras2</ce:section-title><ce:para id="p0130" view="all">Drosophila Ras1 and Ras2 are very similar proteins in sequence, but can be grouped by sequence conservation with true Ras and with Ras-related human counterparts, respectively (<ce:cross-ref id="crosref0295" refid="fig1">Fig.&#160;1</ce:cross-ref><ce:float-anchor refid="fig1"/>A<ce:float-anchor refid="fig2"/>; see (<ce:cross-ref id="crosref0300" refid="bib19">Jancik et&#160;al., 2010</ce:cross-ref>) for a description of Ras functional domains). Both Ras genes are expressed in a generalised manner in the wing disc, the epithelial tissue that gives rise to the adult wing and thorax of the fly (<ce:cross-ref id="crosref0305" refid="fig1">Fig.&#160;1</ce:cross-ref>B&#x2013;E). To visualize the subcellular localization of Ras1 and Ras2, we expressed tagged versions of the proteins in the Ring Gland, a tissue formed by cells much larger than imaginal cells, and observed that normal and activated Ras1 (Ras1<ce:sup loc="post">V12</ce:sup>) and Ras2 (Ras2<ce:sup loc="post">V14</ce:sup>) proteins accumulate in close association with the cell membrane (<ce:cross-ref id="crosref0310" refid="fig1">Fig.&#160;1</ce:cross-ref>F&#x2013;I). The overexpression of activated forms of Ras1 and Ras2 in the wing results in similar but not identical phenotypes. Thus, all Gal4/UAS combinations involving Ras1<ce:sup loc="post">V12</ce:sup> show varying degrees of ectopic vein formation (stronger at higher transgene copy number and temperature; <ce:cross-ref id="crosref0315" refid="fig2">Fig.&#160;2</ce:cross-ref>B and see below), wing folding and in some cases slightly larger wing size (<ce:cross-ref id="crosref0320" refid="appsec1">Supple. Fig.&#160;1</ce:cross-ref>). In the case of Ras2<ce:sup loc="post">V14</ce:sup> overexpression, we also found larger wing size (<ce:cross-ref id="crosref0325" refid="appsec1">Supple. Fig.&#160;1</ce:cross-ref>), ectopic veins and also defects in epithelial integrity, revealed by the formation of balls of wing tissue that are trapped between the dorsal and ventral wing surfaces (<ce:cross-ref id="crosref0330" refid="fig2">Fig.&#160;2</ce:cross-ref>C). Ectopic vein formation and defects in epithelial integrity are stronger when Ras1<ce:sup loc="post">V12</ce:sup> and Ras2<ce:sup loc="post">V14</ce:sup> overexpression is combined (<ce:cross-ref id="crosref0335" refid="fig2">Fig.&#160;2</ce:cross-ref>D), which is compatible with a dose effect of higher levels of activated-Ras expression (Ras1<ce:sup loc="post">v12</ce:sup>/Ras2<ce:sup loc="post">v14</ce:sup>). Knockdown of Ras1 results in smaller than normal wings that fail to differentiate the veins (<ce:cross-ref id="crosref0340" refid="fig2">Fig.&#160;2</ce:cross-ref>E and <ce:cross-ref id="crosref0345" refid="appsec1">Supple. Fig.&#160;1A</ce:cross-ref>). Interestingly, activated Ras2 totally suppresses the <ce:italic>Ras1</ce:italic> loss-of-function phenotype (<ce:cross-ref id="crosref0350" refid="fig2">Fig.&#160;2</ce:cross-ref>F and <ce:cross-ref id="crosref0355" refid="appsec1">Supple. Fig.&#160;1A</ce:cross-ref>), suggesting that Ras2 constitutively activated and overexpressed can substitute for Ras1 function. In summary, the analysis of Ras1 and Ras2 activating mutations suggests that both proteins affect a similar set of target genes with different efficiency when overexpressed.</ce:para></ce:section><ce:section id="sec3.2" view="all"><ce:label>3.2</ce:label><ce:section-title id="sectitle0100">Generation and analysis of Ras2 mutants</ce:section-title><ce:para id="p0135" view="all">To identify the normal requirements of Ras2 during development, we generated a set of <ce:italic>Ras2</ce:italic> loss of function alleles using CRISPR-Cas9 (see material and methods). We selected several frame-shift alleles causing premature stop codons (<ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>1</ce:italic></ce:sup>, <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup>, <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>12</ce:italic></ce:sup> and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>11</ce:italic></ce:sup>; <ce:cross-ref id="crosref0360" refid="fig3">Fig.&#160;3</ce:cross-ref><ce:float-anchor refid="fig3"/>A) and two internal deletions of 5 and 7 amino acids (<ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>10</ce:italic></ce:sup> and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup>, respectively; <ce:cross-ref id="crosref0365" refid="fig3">Fig.&#160;3</ce:cross-ref>A). We focused our analysis on <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup>, a null allele, and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup>, a deletion of 7 amino acids located in the switch I region of Ras2, a domain required for its interaction with GAP proteins and downstream effectors (<ce:cross-ref id="crosref0370" refid="bib6">Castellano and Santos, 2011</ce:cross-ref>; <ce:cross-ref id="crosref0375" refid="bib19">Jancik et&#160;al., 2010</ce:cross-ref>). Flies homozygous for these alleles are viable and fertile, indicating that Ras2 is not required for general viability. In both cases we observe a moderate reduction in wing size (7,6% and 9,4% for <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup>, respectively; <ce:cross-ref id="crosref0380" refid="fig3">Fig.&#160;3B&#x2013;</ce:cross-ref>D and E) mostly caused by lower number of cells (<ce:cross-ref id="crosref0385" refid="fig3">Fig.&#160;3</ce:cross-ref>F and G). Interestingly, and in contrast to <ce:italic>Ras1</ce:italic> loss-of-function conditions, <ce:italic>Ras2</ce:italic> mutants do not affect vein formation (<ce:cross-ref id="crosref0390" refid="fig2">Figs.&#160;2</ce:cross-ref>E and <ce:cross-ref id="crosref0395" refid="fig3">Fig.&#160;3</ce:cross-ref>B&#x2013;D). To further explore the consequences of <ce:italic>Ras2</ce:italic> loss, we measured developmental timing and life span in <ce:italic>Ras2</ce:italic> mutants and control flies. We found that <ce:italic>Ras2</ce:italic> mutants have delayed pupariation (<ce:cross-ref id="crosref0400" refid="fig3">Fig.&#160;3</ce:cross-ref>H) and extended life span in normal growth media (<ce:cross-ref id="crosref0405" refid="fig3">Fig.&#160;3</ce:cross-ref>I). This last phenotype is stronger in <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> flies, perhaps because this mutant might interact with upstream activators, but not with downstream effectors, and consequently could display a dominant-negative effect on Ras activity. Extended life span is also caused by lower than normal levels of <ce:italic>Ras1</ce:italic> in specific tissues (<ce:cross-ref id="crosref0410" refid="bib43">Slack et&#160;al., 2015</ce:cross-ref>).</ce:para></ce:section><ce:section id="sec3.3" view="all"><ce:label>3.3</ce:label><ce:section-title id="sectitle0105">Ras2/Ras1 genetic interactions</ce:section-title><ce:para id="p0140" view="all">We wondered whether the mild phenotypes caused by loss of <ce:italic>Ras2</ce:italic> might be due to compensation by Ras1 activity. To analyse this possibility, we reduced <ce:italic>Ras1</ce:italic> expression in a <ce:italic>Ras2</ce:italic> mutant background (<ce:cross-ref id="crosref0415" refid="fig4">Fig.&#160;4</ce:cross-ref><ce:float-anchor refid="fig4"/>A and B). We found that loss of <ce:italic>Ras2</ce:italic> increases the phenotype of smaller wing size and cell size caused by reduced expression of <ce:italic>Ras1</ce:italic> (<ce:cross-ref id="crosref0420" refid="fig4">Fig.&#160;4</ce:cross-ref>C&#x2013;E), suggesting some degree of functional similarity between Ras1 and Ras2 in this experimental setting.</ce:para></ce:section><ce:section id="sec3.4" view="all"><ce:label>3.4</ce:label><ce:section-title id="sectitle0110">Effects of Ras1 and Ras2 activation on InR and EGFR signalling</ce:section-title><ce:para id="p0145" view="all">Ras proteins function downstream of activated tyrosine kinase transmembrane receptors such as InR and EGFR. The activation of EGFR leads to the phosphorylation in Ser/Thr and Tyr residues of the MAP kinase ERK. In the wing pouch region of the wing disc phosphorylated ERK (dP-ERK) is mostly accumulated in the developing longitudinal veins and in two stripes of cells abutting the wing margin (<ce:cross-ref id="crosref0425" refid="bib12">Gabay et&#160;al., 1997</ce:cross-ref>, <ce:cross-ref id="crosref0430" refid="fig5">Fig.&#160;5</ce:cross-ref><ce:float-anchor refid="fig5"/>A<ce:float-anchor refid="fig6"/><ce:float-anchor refid="fig7"/>-A&#x2032;). As expected, expression of activated EGFR increases dP-ERK accumulation (<ce:cross-ref id="crosref0435" refid="fig5">Fig.&#160;5</ce:cross-ref>B-B&#x2032;), whereas expression of RNAi against ERK reduces dP-ERK (<ce:cross-ref id="crosref0440" refid="fig5">Fig.&#160;5</ce:cross-ref>C-C&#x2032;). Overexpression of Ras1<ce:sup loc="post">V12</ce:sup> (<ce:cross-ref id="crosref0445" refid="fig5">Fig.&#160;5</ce:cross-ref>D-D&#x2032;) and Ras2<ce:sup loc="post">V14</ce:sup> (<ce:cross-ref id="crosref0450" refid="fig5">Fig.&#160;5</ce:cross-ref>E-E&#x2032;) increase ERK phosphorylation, and this effect is stronger in the case of Ras1<ce:sup loc="post">V12</ce:sup> (compare <ce:cross-ref id="crosref0455" refid="fig5">Fig.&#160;5</ce:cross-ref> D&#x2032; and E&#x2019;).</ce:para><ce:para id="p0150" view="all">We used Akt phosphorylation as reporter of InR activation in <ce:italic>Ras2</ce:italic> mutant larvae and in imaginal discs bearing <ce:italic>Ras1</ce:italic> and <ce:italic>Ras2</ce:italic> activating mutations. First we measured the levels of total Akt and P-Akt in protein extracts from <ce:italic>Ras2</ce:italic> mutant larvae We found a weak but significant reduction in the level of P-Akt in <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> larvae (28%; <ce:cross-ref id="crosref0460" refid="fig5">Fig.&#160;5</ce:cross-ref>F and G). In the case of <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> we also found a weak reduction in P-Akt (16%) that was not statistically significant (<ce:cross-ref id="crosref0465" refid="fig5">Fig.&#160;5</ce:cross-ref>F and G). The different quantitative effect of <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> is likely due to a Ras2<ce:sup loc="post">17</ce:sup> mutant protein dominant negative effect, as also observed in lifespan experiments. A systemic reduction of P-Akt in mutant <ce:italic>Ras2</ce:italic> larvae is compatible with a requirement of Ras2 to reach normal levels of InR activity. We also measure total Erk and dP-Erk in <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>3</ce:italic></ce:sup> and <ce:italic>Ras2</ce:italic><ce:sup loc="post"><ce:italic>17</ce:italic></ce:sup> mutant larvae, but we did not detect a significant difference in the levels of dP-Erk comparing <ce:italic>Ras2</ce:italic> mutant larvae to controls (<ce:cross-ref id="crosref0470" refid="fig5">Fig.&#160;5</ce:cross-ref>F and G).</ce:para><ce:para id="p0155" view="all">P-Akt is detected in the cytoplasm of all wing imaginal disc cells at similar levels (<ce:cross-ref id="crosref0475" refid="fig6">Fig.&#160;6</ce:cross-ref>A-A&#x2032; and I). We could not detect obvious changes in P-Akt accumulation when either Ras1<ce:sup loc="post">V12</ce:sup> (<ce:cross-ref id="crosref0480" refid="fig6">Fig.&#160;6</ce:cross-ref>B-B&#x2019;and I) or Ras2<ce:sup loc="post">V14</ce:sup> (<ce:cross-ref id="crosref0485" refid="fig6">Fig.&#160;6</ce:cross-ref>C-C&#x2033; and I) are overexpressed in the central region of the wing blade. In contrast, and as expected, the expression of activated forms of the InR results in a strong increase in the accumulation of P-Akt (<ce:cross-ref id="crosref0490" refid="fig6">Fig.&#160;6</ce:cross-ref>F-F&#x2032; and I; <ce:cross-ref id="crosref0495" refid="appsec1">Supple. Fig.&#160;1C</ce:cross-ref>), and the expression of Akt-RNAi leads to a strong depletion of P-Akt (<ce:cross-ref id="crosref0500" refid="fig6">Fig.&#160;6</ce:cross-ref>H-Hi, I and <ce:cross-ref id="crosref0505" refid="appsec1">Supple. Fig.&#160;1C</ce:cross-ref>). The reduction of PTEN expression in the central domain of the wing disc also causes a significant increase in the accumulation of P-AKT (<ce:cross-ref id="crosref0510" refid="fig6">Fig.&#160;6</ce:cross-ref>G-G&#x2032; and I). We also expressed and analysed P-Akt accumulation upon stronger expression of Ras1<ce:sup loc="post">V12</ce:sup> and Ras2<ce:sup loc="post">V14</ce:sup> in the posterior compartment using the <ce:italic>hh-Gal4</ce:italic> driver (<ce:cross-ref id="crosref0515" refid="fig6">Fig.&#160;6</ce:cross-ref>D&#x2013;E and L). In these genetic backgrounds (<ce:italic>UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup><ce:italic>/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; hh-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;; <ce:cross-ref id="crosref0520" refid="fig6">Fig.&#160;6</ce:cross-ref>D-D&#180;&#180;&#180;and <ce:italic>UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup><ce:italic>/</ce:italic>&#160;&#x200b;+&#160;&#x200b;<ce:italic>; hh-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;; <ce:cross-ref id="crosref0525" refid="fig6">Fig.&#160;6</ce:cross-ref>E-E&#180;&#180;&#180;) we could detect a significant increase in the accumulation of P-Akt in posterior compartments expressing Ras1<ce:sup loc="post">V12</ce:sup> or Ras2<ce:sup loc="post">V14</ce:sup> versus the anterior ones (<ce:cross-ref id="crosref0530" refid="fig6">Fig.&#160;6</ce:cross-ref>J). These results indicate that only high levels of Ras1<ce:sup loc="post">V12</ce:sup> or Ras2<ce:sup loc="post">V14</ce:sup> are effective in promoting P-Akt phosphorylation.</ce:para></ce:section><ce:section id="sec3.5" view="all"><ce:label>3.5</ce:label><ce:section-title id="sectitle0115">Functional relationships between Ras proteins and insulin receptor/EGFR signalling</ce:section-title><ce:para id="p0160" view="all">The phenotypes observed in <ce:italic>Ras2</ce:italic> mutant flies and its requirement to achieve normal levels of Akt phosphorylation are compatible with a weak and generalised reduction in InR signalling in <ce:italic>Ras2</ce:italic> mutant cells (<ce:cross-ref id="crosref0535" refid="bib3">Broughton et&#160;al., 2005</ce:cross-ref>; <ce:cross-ref id="crosref0540" refid="bib15">Haselton et&#160;al., 2010</ce:cross-ref>). However, even moderate changes of InR activity in the wing disc result in stronger effects on wing size than the ones produced by <ce:italic>Ras2</ce:italic> mutants (<ce:cross-ref id="crosref0545" refid="fig7">Fig.&#160;7</ce:cross-ref>A&#x2013;C; <ce:cross-ref id="crosref0550" refid="appsec1">Supple. Fig.&#160;1B</ce:cross-ref>), indicating that this pathway can operate in the absence of Ras2 activity. To further explore the possible relationships between Ras2 and InR signalling, we first analysed the ability of activated forms of Ras1 and Ras2 to compensate for a reduction in the activity of the InR. As expected, the overexpression of a dominant negative version of the receptor (InR<ce:sup loc="post">DN</ce:sup>) results in a strong reduction in the level of P-Akt accumulation (<ce:cross-ref id="crosref0555" refid="fig7">Fig.&#160;7</ce:cross-ref>D and E and <ce:cross-ref id="crosref0560" refid="appsec1">Supple. Fig.&#160;1C</ce:cross-ref>). In this genetic background (<ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-GFP</ce:italic>) the introduction of activated forms of Ras1 (<ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup>) and Ras2 (<ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup>) partially rescued the loss of P-Akt (<ce:cross-ref id="crosref0565" refid="fig7">Fig.&#160;7</ce:cross-ref>F and G and <ce:cross-ref id="crosref0570" refid="appsec1">Supple. Fig.&#160;1C</ce:cross-ref>). The expression of activated Ras2 is much more effective that Ras1<ce:sup loc="post">V12</ce:sup> in the rescue of P-Akt accumulation (the quantifications of relative P-Akt intensity levels are shown in <ce:cross-ref id="crosref0575" refid="appsec1">Supple. Fig.&#160;1C</ce:cross-ref>). These changes in P-Akt accumulation are also manifest in the resulting adult wings. Thus, expression of InR<ce:sup loc="post">DN</ce:sup> causes a strong reduction in wing size (<ce:cross-ref id="crosref0580" refid="fig7">Fig.&#160;7</ce:cross-ref>B, H and <ce:cross-ref id="crosref0585" refid="appsec1">Supple. Fig.&#160;1A</ce:cross-ref>) that is partially compensated by Ras2<ce:sup loc="post">V14</ce:sup> (<ce:cross-ref id="crosref0590" refid="fig7">Fig.&#160;7</ce:cross-ref>M and <ce:cross-ref id="crosref0595" refid="appsec1">Supple. Fig.&#160;1A</ce:cross-ref>) but not by Ras1<ce:sup loc="post">V12</ce:sup> (<ce:cross-ref id="crosref0600" refid="fig7">Fig.&#160;7</ce:cross-ref>J). These wings still display the characteristic excess of vein formation caused by Ras1<ce:sup loc="post">V12</ce:sup> and Ras2<ce:sup loc="post">V14</ce:sup> expression (<ce:cross-ref id="crosref0605" refid="fig7">Fig.&#160;7</ce:cross-ref>I and L, respectively). Knock down of <ce:italic>dp110</ce:italic>, encoding the catalytic subunit of the insulin pathway effector PI3K, results in wing size reduction (<ce:cross-ref id="crosref0610" refid="fig7">Fig.&#160;7</ce:cross-ref>N and <ce:cross-ref id="crosref0615" refid="appsec1">Supple. Fig.&#160;1A</ce:cross-ref>) that cannot be restored when activated Ras2 is overexpressed (<ce:cross-ref id="crosref0620" refid="fig7">Fig.&#160;7</ce:cross-ref>P and <ce:cross-ref id="crosref0625" refid="appsec1">Supple. Fig.&#160;1A</ce:cross-ref>). Similarly, overexpression of Ras1<ce:sup loc="post">V12</ce:sup> in the <ce:italic>dp110</ce:italic> knock down background is not able to rescue the wing size reduction caused by <ce:italic>dp110</ce:italic> loss. Thus, <ce:italic>Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup><ce:italic>/dp110-RNAi</ce:italic> wings are very reduced in size and display a strong phenotype of ectopic vein differentiation (<ce:cross-ref id="crosref0630" refid="fig7">Fig.&#160;7</ce:cross-ref>O). These results are compatible with Ras2<ce:sup loc="post">V14</ce:sup> being more effective than Ras1<ce:sup loc="post">V12</ce:sup> in rescuing the lost of InR activity.</ce:para><ce:para id="p0165" view="all">We used a similar approach to analyse the contribution of Ras1 and Ras2 to EGFR signalling. First, we confirmed that the presence of EGFR<ce:sup loc="post">DN</ce:sup> reduces the accumulation of dP-ERK (<ce:cross-ref id="crosref0635" refid="fig7">Fig.&#160;7</ce:cross-ref>R compare with 7Q). In this EGFR<ce:sup loc="post">DN</ce:sup> background, both Ras2<ce:sup loc="post">V14</ce:sup> (<ce:cross-ref id="crosref0640" refid="fig7">Fig.&#160;7</ce:cross-ref>S) and Ras1<ce:sup loc="post">V12</ce:sup> (<ce:cross-ref id="crosref0645" refid="fig7">Fig.&#160;7</ce:cross-ref>T) are able to promote the accumulation of dP-ERK. The corresponding adult phenotypes are consistent with the changes observed in dP-ERK accumulation. Thus both Ras1<ce:sup loc="post">V12</ce:sup> and Ras2<ce:sup loc="post">V14</ce:sup> expression is able to promote vein formation in the EGFR<ce:sup loc="post">DN</ce:sup> background (Fig.&#160;7U&#x2013;W). These results suggest that in the wing epithelia Ras1 would be acting mainly through the Raf/MAPK signalling cascade and both Ras1 and Ras2 would be able to activate this pathway when over-expressed and constitutively activated.</ce:para></ce:section><ce:section id="sec3.6" view="all"><ce:label>3.6</ce:label><ce:section-title id="sectitle0120">Ras2-Dp110 and Ras2-Raf molecular interactions</ce:section-title><ce:para id="p0170" view="all">Ras1 can engage in molecular interactions with Raf and Dp110, although it is mostly required to activate Raf (<ce:cross-ref id="crosref0650" refid="bib29">Orme et&#160;al., 2006</ce:cross-ref>). To analyse the possibility of Ras2 interactions with Raf and Dp110 we did pull-down and immunoprecipitation assays. In pull-down experiments, we translated <ce:italic>in vitro</ce:italic> Raf and Dp110 and searched for direct interactions with Ras2 and with its activated form Ras2<ce:sup loc="post">V14</ce:sup>. We found that Ras2 and Ras2<ce:sup loc="post">V14</ce:sup> interact with both Raf and Dp110 (<ce:cross-ref id="crosref0655" refid="fig8">Fig.&#160;8</ce:cross-ref><ce:float-anchor refid="fig8"/>I). The Ras2/Dp110 interaction appears stronger than the Ras2/Raf one (2 vs 0.7% of total Dp110 and Raf found in the pull down assay respectively), and the strength of both interactions increases when we used the Ras2<ce:sup loc="post">V14</ce:sup> form (4.6% vs 1.5% of total Dp110 and Raf) (<ce:cross-ref id="crosref0660" refid="fig8">Fig.&#160;8</ce:cross-ref>I). We also studied the possibility of <ce:italic>in vivo</ce:italic> interactions between Ras2 and Dp110 by immunoprecipitation using extracts obtained from embryos expressing tagged versions of both proteins (<ce:cross-ref id="crosref0665" refid="fig8">Fig.&#160;8</ce:cross-ref>J). We observed Ras2/Dp110 interaction in embryos expressing an activated form of the InR, Ras2 and Dp110 (<ce:cross-ref id="crosref0670" refid="fig8">Fig.&#160;8</ce:cross-ref>J) and inconsistently in embryos expressing only Ras2 and Dp110 (data not shown). These results indicate that Ras2 can interact directly or indirectly with Dp110 and Raf, and that Ras2 could be part of a protein complex including Dp110 <ce:italic>in vivo</ce:italic>.</ce:para></ce:section></ce:section><ce:section id="sec4" role="discussion" view="all"><ce:label>4</ce:label><ce:section-title id="sectitle0125">Discussion</ce:section-title><ce:para id="p0175" view="all">Ras and Ras-related proteins connect activated transmembrane receptors with different downstream effectors. These proteins share extensive sequence identity, and differ mostly in the C-terminal part of the protein, the HVR, which is involved in the regulation of their subcellular localization (<ce:cross-ref id="crosref0675" refid="bib5">Castellano and Downward, 2011</ce:cross-ref>). Murine and human Ras and Ras-related proteins interact with both Raf and PI3K, and both pathways cooperate to regulate cellular growth through the phosphorylation and inactivation of Tsc2 (<ce:cross-ref id="crosref0680" refid="bib18">Inoki et&#160;al., 2002</ce:cross-ref>; <ce:cross-ref id="crosref0685" refid="bib25">Ma et&#160;al., 2005</ce:cross-ref>). True Ras and Ras-related proteins have Ras1 and Ras2 as orthologous proteins in Drosophila, respectively, and this facilitates the analysis of their functional requirements and the identification of their downstream targets. In this sense, whereas Ras1 has been thoroughly characterised, there are very few data on Ras2, and no mutants affecting the gene had been identified so far.</ce:para><ce:para id="p0180" view="all">We have generated and characterised a set of <ce:italic>Ras2</ce:italic> alleles, and find that Ras2 function is not required for Drosophila development or viability. This is in stark contrast to <ce:italic>Ras1</ce:italic> mutations, which are embryonic lethal and display alterations in all developmental processes involving the activity of the ERK signalling pathway (<ce:cross-ref id="crosref0690" refid="bib39">Schweitzer and Shilo, 1997</ce:cross-ref>; <ce:cross-ref id="crosref0695" refid="bib47">Wassarman et&#160;al., 1995</ce:cross-ref>). The different behaviour of <ce:italic>Ras1</ce:italic> and <ce:italic>Ras2</ce:italic> mutations indicates that Ras1 suffices to provide Ras function compatible with the normal activation of their downstream effectors. However, and although Ras2 is not required for organism viability, mutant <ce:italic>Ras2</ce:italic> flies show phenotypes affecting organ size and life span. These phenotypes are similar but weaker than those caused by impaired InR signalling (<ce:cross-ref id="crosref0700" refid="bib3">Broughton et&#160;al., 2005</ce:cross-ref>; <ce:cross-ref id="crosref0705" refid="bib15">Haselton et&#160;al., 2010</ce:cross-ref>), suggesting that Ras2 might have a role in the generation of physiological levels of InR signalling even in the presence of Ras1. In agreement, we found that Ras2 can interact with the catalytic subunit of PI3K (Dp110), a downstream effector of InR signalling, and that <ce:italic>Ras2</ce:italic> mutant flies accumulate lower levels of P-Akt.</ce:para><ce:para id="p0185" view="all">The activation of the InR leads to the production of phosphatidylinositol (3,4,5) triphosphate (PIP<ce:inf loc="post">3</ce:inf>) through the kinase activity of the Dp110/p60 PI3K complex (<ce:cross-ref id="crosref0710" refid="bib24">Lizcano and Alessi, 2002</ce:cross-ref>). The generation of PIP<ce:inf loc="post">3</ce:inf> recruits both phosphatidylinositol-dependent kinase 1 (PDK1) and Akt to the membrane. Phosphorylated and activated Akt phosphorylates several effectors including the transcription factor Foxo, which is then retained in the cytoplasm, and the small GTPase activating proteins TSC1/2, leading to the activation of the TORC1 complex and to the promotion of ribosomal biogenesis and protein synthesis (<ce:cross-ref id="crosref0715" refid="bib24">Lizcano and Alessi, 2002</ce:cross-ref>). A key aspect of InR signalling is that the receptor can use several complementary mechanisms to activate PI3K, including direct binding of the receptor to the regulatory subunit of PI3K (p60), binding of the receptor to PI3K through the molecular adaptor Chico and recruitment of Ras by the receptor leading to stimulation of PI3K (<ce:cross-ref id="crosref0720" refid="bib5">Castellano and Downward, 2011</ce:cross-ref>). Consequently, Ras2 function might be just one among several routes from InR to PI3K, and this might explain why <ce:italic>Ras2</ce:italic> mutants are viable and only display weak InR-related phenotypes. In agreement, flies with a mutated PI3K unable to bind Ras proteins (PI3K<ce:sup loc="post">RBD</ce:sup>) are viable, but display phenotypes characteristic of reduced InR signalling (<ce:cross-ref id="crosref0725" refid="bib29">Orme et&#160;al., 2006</ce:cross-ref>; <ce:cross-ref id="crosref0730" refid="bib33">Prober and Edgar, 2002</ce:cross-ref>). PI3K<ce:sup loc="post">RBD</ce:sup> flies show stronger phenotypes than <ce:italic>Ras2</ce:italic> mutant flies, and in particular they present a reduction in body size (<ce:cross-ref id="crosref0735" refid="bib29">Orme et&#160;al., 2006</ce:cross-ref>). The differences between <ce:italic>PI3K</ce:italic><ce:sup loc="post"><ce:italic>RBD</ce:italic></ce:sup> and <ce:italic>Ras2</ce:italic> mutant flies could be explained if Ras1 can partially rescue PI3K activation in <ce:italic>Ras2</ce:italic> mutants, but not in <ce:italic>PI3K</ce:italic><ce:sup loc="post"><ce:italic>RBD</ce:italic></ce:sup> animals.</ce:para><ce:para id="p0190" view="all">Our findings related to Drosophila Ras2 are very much compatible with the biochemical characteristics of its closest human orthologous, R-Ras2/TC21. In this manner, knockout mice for <ce:italic>TC21</ce:italic>, as well as double knockout <ce:italic>R-Ras1</ce:italic><ce:sup loc="post">&#x2212;/&#x2212;&#x2013;&#x2013;</ce:sup><ce:italic>; R-Ras2</ce:italic><ce:sup loc="post">&#x2212;/&#x2212;&#x2013;&#x2013;</ce:sup> mice, are viable in homozygosis (<ce:cross-ref id="crosref0740" refid="bib17">Iborra et&#160;al., 2011</ce:cross-ref>; <ce:cross-ref id="crosref0745" refid="bib38">Sanz-Rodriguez et&#160;al., 2018</ce:cross-ref>). In addition, TC21 is implicated in the regulation of growth-promoting pathways, and both Raf and PI3K act as direct effectors required for TC21-induced transformation (<ce:cross-ref id="crosref0750" refid="bib26">Movilla et&#160;al., 1999</ce:cross-ref>; <ce:cross-ref id="crosref0755" refid="bib35">Rosario et&#160;al., 1999</ce:cross-ref>, <ce:cross-ref id="crosref0760" refid="bib36">2001</ce:cross-ref>). Specifically, TC21 has also been implicated in the survival and maturation of T cells, and in this system participates upstream of PI3K to provide physiological levels of PI3K activity (<ce:cross-ref id="crosref0765" refid="bib9">Delgado et&#160;al., 2009</ce:cross-ref>; <ce:cross-ref id="crosref0770" refid="bib17">Iborra et&#160;al., 2011</ce:cross-ref>). Similarly, TC21 has been described to play a role in oligodendrocyte differentiation through activation of both PI3K/Akt and Raf/MAPK pathways (<ce:cross-ref id="crosref0775" refid="bib38">Sanz-Rodriguez et&#160;al., 2018</ce:cross-ref>).</ce:para><ce:para id="p0195" view="all">The situation observed at normal levels of Ras expression is somewhat altered when these proteins are insensitive to GAP regulation, i.e. constitutively bound to GTP, and overexpressed. In this manner, both activated Ras1 and Ras2 are able to compensate for a loss of EGFR activity, and activated Ras2 can supply Ras function upon a reduction of <ce:italic>Ras1</ce:italic> expression. In addition, activated Ras2 more effectively compensates for a reduction in InR activity than activated Ras1, rescuing both the loss of P-Akt and the phenotype caused by InR loss of function. Finally, both Ras1 and Ras2 are able to promote P-Akt accumulation in the wing disc when activated by mutation, but only when these mutant proteins are expressed at high levels. All together, these results suggest that Ras1 and Ras2 retain to some extent the ability to interact with a similar set of effectors, but that at physiological levels of expression Ras1 is necessary and sufficient to implement Raf activation downstream of EGFR and Ras2 is part of one among several possible mechanisms linking InR function to PI3K activation.</ce:para></ce:section></ce:sections><ce:acknowledgment id="ack0010" view="all"><ce:section-title id="sectitle0130">Acknowledgments</ce:section-title><ce:para id="p0200" view="all">We thank the Hybridome bank at Iowa University, NIG-FLy in Japan, Bloomington Stock Center and VDRC Stock Center for providing the tools necessary for this work. This research was supported by <ce:grant-sponsor id="gs1" sponsor-id="https://doi.org/10.13039/501100007136" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor" xlink:type="simple">Secretar&#237;a de Estado de Investigaci&#243;n, Desarrollo e Innovaci&#243;n</ce:grant-sponsor>, Grant/Award Number: <ce:grant-number refid="gs1">BFU2015-64220-P</ce:grant-number> and <ce:grant-number refid="gs1">BFU2018-094476</ce:grant-number>. We would also like to acknowledge the support from the Drosophila transgenesis and confocal microscopy CBMSO scientific services. The CBMSO enjoys institutional support from the Ram&#243;n Areces and Santander Foundations.</ce:para></ce:acknowledgment><ce:appendices view="all"><ce:section id="appsec1" view="extended"><ce:label>Appendix A</ce:label><ce:section-title id="sectitle0135">Supplementary data</ce:section-title><ce:para id="p0205" view="all">The following are the Supplementary data to this article:<ce:display><ce:e-component id="mmc1"><ce:label>Application</ce:label><ce:caption id="cap0010"><ce:simple-para id="espara0010" view="all">Statistical analysis of wing sizes and P-Akt levels of expression.</ce:simple-para><ce:simple-para id="espara0015" view="all">(A) Average size of the wing region included between the veins L2 and L5 (domain of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4</ce:italic> expression) in the genetic combinations described in <ce:cross-ref id="crosref0780" refid="fig2">Fig.&#160;2</ce:cross-ref>A&#x2013;C, E-F and <ce:cross-ref id="crosref0785" refid="fig7">Fig.&#160;7</ce:cross-ref> H, I, K, L, M, N and P). We only measured wing size in those cases in which the wing blade is fully extended. In the combinations <ce:italic>sal-Gal4 UAS-GFP/UAS Dp110-i</ce:italic> and <ce:italic>sal-Gal4 UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup><ce:italic>/UAS-Dp110-i</ce:italic> is shown the entire wing area (B) Ratio of posterior to anterior compartment size in wings presented in <ce:cross-ref id="crosref0790" refid="fig7">Fig.&#160;7</ce:cross-ref>A&#x2013;C (<ce:italic>enGal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;; <ce:italic>enGal4/UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup> and <ce:italic>enGal4/UAS-InR*</ce:italic>). (C) Average ratio of P-Akt signal intensity between mutant and normal wing blade regions in wing discs of <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/</ce:italic>&#160;&#x200b;+&#160;&#x200b;(wt; see <ce:cross-ref id="crosref0795" refid="fig6">Fig.&#160;6</ce:cross-ref>A&#x2019;); <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-InR*;</ce:italic> see <ce:cross-ref id="crosref0800" refid="fig6">Fig.&#160;6</ce:cross-ref>F&#x2019;), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup> (see <ce:cross-ref id="crosref0805" refid="fig7">Fig.&#160;7</ce:cross-ref>E), <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-GFP/UAS-Akt-RNAi</ce:italic> (see <ce:cross-ref id="crosref0810" refid="fig5">Fig.&#160;5</ce:cross-ref>H&#x2019;), and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS- InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup> (see <ce:cross-ref id="crosref0815" refid="fig7">Fig.&#160;7</ce:cross-ref>F) and <ce:italic>sal</ce:italic><ce:sup loc="post"><ce:italic>EPv</ce:italic></ce:sup><ce:italic>-Gal4 UAS-InR</ce:italic><ce:sup loc="post"><ce:italic>DN</ce:italic></ce:sup><ce:italic>/UAS-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup> (see <ce:cross-ref id="crosref0820" refid="fig7">Fig.&#160;7</ce:cross-ref>G).</ce:simple-para></ce:caption><ce:alt-text id="alttext0010" role="short">Application</ce:alt-text><ce:link locator="mmc1" xlink:href="pii:S0012160620300609/mmc1" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/46.1" xlink:type="simple"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc2"><ce:label>Application</ce:label><ce:caption id="cap0015"><ce:simple-para id="espara0020" view="all">Oligonucleotides used and cloning method of <ce:italic>UAS-Raf-Myc</ce:italic>, <ce:italic>UAS-PI3K-Myc</ce:italic>, <ce:italic>UAS-Flag-Ras1</ce:italic>, <ce:italic>UAS-Flag-Ras1</ce:italic><ce:sup loc="post"><ce:italic>V12</ce:italic></ce:sup>, <ce:italic>UAS-Flag-Ras2</ce:italic> and <ce:italic>UAS-Flag-Ras2</ce:italic><ce:sup loc="post"><ce:italic>V14</ce:italic></ce:sup>.</ce:simple-para></ce:caption><ce:alt-text id="alttext0015" role="short">Application</ce:alt-text><ce:link locator="mmc2" xlink:href="pii:S0012160620300609/mmc2" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/46.1" xlink:type="simple"/></ce:e-component></ce:display></ce:para></ce:section><ce:section id="appsec2" view="compact-standard"><ce:label>Appendix A</ce:label><ce:section-title id="sectitle0140">Supplementary data</ce:section-title><ce:para id="p0210" view="all">Supplementary data to this article can be found online at <ce:inter-ref id="intref0015" xlink:href="https://doi.org/10.1016/j.ydbio.2020.02.009" xlink:type="simple">https://doi.org/10.1016/j.ydbio.2020.02.009</ce:inter-ref>.</ce:para></ce:section></ce:appendices></ja:body><ja:tail view="all"><ce:bibliography id="cebib0010" view="all"><ce:section-title id="sectitle0145">References</ce:section-title><ce:bibliography-sec id="cebibsec0010" view="all"><ce:bib-reference id="bib1"><ce:label>Bernards, 2003</ce:label><sb:reference id="sref1"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Bernards</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochim. Biophys. Acta</sb:maintitle></sb:title><sb:volume-nr>1603</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>47</sb:first-page><sb:last-page>82</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0015">Bernards, A., 2003. GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. Biochimica et biophysica acta 1603, 47-82.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>Bishop and Corces, 1988</ce:label><sb:reference id="sref2"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.G.</ce:given-name><ce:surname>Bishop</ce:surname><ce:suffix>3rd</ce:suffix></sb:author><sb:author><ce:given-name>V.G.</ce:given-name><ce:surname>Corces</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Expression of an activated ras gene causes developmental abnormalities in transgenic Drosophila melanogaster</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genes Dev.</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>567</sb:first-page><sb:last-page>577</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0020">Bishop, J.G., 3rd, Corces, V.G., 1988. Expression of an activated ras gene causes developmental abnormalities in transgenic Drosophila melanogaster. Genes &amp; Development 2, 567-577.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>Broughton et&#160;al., 2005</ce:label><sb:reference id="sref3"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Broughton</ce:surname></sb:author><sb:author><ce:given-name>M.D.</ce:given-name><ce:surname>Piper</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Ikeya</ce:surname></sb:author><sb:author><ce:given-name>T.M.</ce:given-name><ce:surname>Bass</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Jacobson</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Driege</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Martinez</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Hafen</ce:surname></sb:author><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>Withers</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Leevers</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Partridge</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A</sb:maintitle></sb:title><sb:volume-nr>102</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>3105</sb:first-page><sb:last-page>3110</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0025">Broughton, S.J., Piper, M.D., Ikeya, T., Bass, T.M., Jacobson, J., Driege, Y., Martinez, P., Hafen, E., Withers, D.J., Leevers, S.J., Partridge, L., 2005. Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proceedings of the National Academy of Sciences of the United States of America 102, 3105-3110.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>Calleja et&#160;al., 1996</ce:label><sb:reference id="sref4"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Calleja</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Moreno</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Pelaz</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Morata</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Visualization of gene expression in living adult Drosophila</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>274</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>252</sb:first-page><sb:last-page>255</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0030">Calleja, M., Moreno, E., Pelaz, S., Morata, G., 1996. Visualization of gene expression in living adult Drosophila. Science 274, 252-255.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>Castellano and Downward, 2011</ce:label><sb:reference id="sref5"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Castellano</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Downward</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>RAS interaction with PI3K: more than just another effector pathway</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Gene Canc.</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>261</sb:first-page><sb:last-page>274</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0035">Castellano, E., Downward, J., 2011. RAS Interaction with PI3K: More Than Just Another Effector Pathway. Genes &amp; cancer 2, 261-274.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>Castellano and Santos, 2011</ce:label><sb:reference id="sref6"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Castellano</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Santos</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Functional specificity of ras isoforms: so similar but so different</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Gene Canc.</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>216</sb:first-page><sb:last-page>231</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0040">Castellano, E., Santos, E., 2011. Functional specificity of ras isoforms: so similar but so different. Genes &amp; cancer 2, 216-231.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>Cruz et&#160;al., 2009</ce:label><sb:reference id="sref7"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Cruz</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Glavic</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Casado</ce:surname></sb:author><sb:author><ce:given-name>J.F.</ce:given-name><ce:surname>de Celis</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A&#160;gain-of-function screen identifying genes required for growth and pattern formation of the Drosophila melanogaster wing</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genetics</sb:maintitle></sb:title><sb:volume-nr>183</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>1005</sb:first-page><sb:last-page>1026</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0045">Cruz, C., Glavic, A., Casado, M., de Celis, J.F., 2009. A gain-of-function screen identifying genes required for growth and pattern formation of the Drosophila melanogaster wing. Genetics 183, 1005-1026.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>de Celis, 1997</ce:label><sb:reference id="sref8"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.F.</ce:given-name><ce:surname>de Celis</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Expression and function of decapentaplegic and thick veins during the differentiation of the veins in the Drosophila wing</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>124</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>1007</sb:first-page><sb:last-page>1018</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0050">de Celis, J.F., 1997. Expression and function of decapentaplegic and thick veins during the differentiation of the veins in the Drosophila wing. Development 124, 1007-1018.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>Delgado et&#160;al., 2009</ce:label><sb:reference id="sref9"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Delgado</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Cubelos</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Calleja</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Martinez-Martin</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Cipres</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Merida</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Bellas</ce:surname></sb:author><sb:author><ce:given-name>X.R.</ce:given-name><ce:surname>Bustelo</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Alarcon</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Essential function for the GTPase TC21 in homeostatic antigen receptor signaling</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Immunol.</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>880</sb:first-page><sb:last-page>888</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0055">Delgado, P., Cubelos, B., Calleja, E., Martinez-Martin, N., Cipres, A., Merida, I., Bellas, C., Bustelo, X.R., Alarcon, B., 2009. Essential function for the GTPase TC21 in homeostatic antigen receptor signaling. Nat Immunol 10, 880-888.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>Diaz-Benjumea and Hafen, 1994</ce:label><sb:reference id="sref10"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>F.J.</ce:given-name><ce:surname>Diaz-Benjumea</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Hafen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The sevenless signalling cassette mediates Drosophila EGF receptor function during epidermal development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>120</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>569</sb:first-page><sb:last-page>578</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0060">Diaz-Benjumea, F.J., Hafen, E., 1994. The sevenless signalling cassette mediates Drosophila EGF receptor function during epidermal development. Development 120, 569-578.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>Esteban et&#160;al., 2001</ce:label><sb:reference id="sref11"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.M.</ce:given-name><ce:surname>Esteban</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Vicario-Abejon</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Fernandez-Salguero</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Fernandez-Medarde</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Swaminathan</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Yienger</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Lopez</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Malumbres</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>McKay</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Ward</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pellicer</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Santos</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>1444</sb:first-page><sb:last-page>1452</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0065">Esteban, L.M., Vicario-Abejon, C., Fernandez-Salguero, P., Fernandez-Medarde, A., Swaminathan, N., Yienger, K., Lopez, E., Malumbres, M., McKay, R., Ward, J.M., Pellicer, A., Santos, E., 2001. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Molecular and cellular biology 21, 1444-1452.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>Gabay et&#160;al., 1997</ce:label><sb:reference id="sref12"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Gabay</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Seger</ce:surname></sb:author><sb:author><ce:given-name>B.Z.</ce:given-name><ce:surname>Shilo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>MAP kinase in situ activation atlas during Drosophila embryogenesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>124</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>3535</sb:first-page><sb:last-page>3541</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0070">Gabay, L., Seger, R., Shilo, B.Z., 1997. MAP kinase in situ activation atlas during Drosophila embryogenesis. Development 124, 3535-3541.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>Graham et&#160;al., 1994</ce:label><sb:reference id="sref13"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Graham</ce:surname></sb:author><sb:author><ce:given-name>A.D.</ce:given-name><ce:surname>Cox</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Drivas</ce:surname></sb:author><sb:author><ce:given-name>M.G.</ce:given-name><ce:surname>Rush</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>D&#x2019;Eustachio</ce:surname></sb:author><sb:author><ce:given-name>C.J.</ce:given-name><ce:surname>Der</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>4108</sb:first-page><sb:last-page>4115</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0075">Graham, S.M., Cox, A.D., Drivas, G., Rush, M.G., D&#x2019;Eustachio, P., Der, C.J., 1994. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation. Mol Cell Biol 14, 4108-4115.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>Guichard et&#160;al., 1999</ce:label><sb:reference id="sref14"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Guichard</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Biehs</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Sturtevant</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Wickline</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chacko</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Howard</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Bier</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Rhomboid and Star interact synergistically to promote EGFR/MAPK signaling during Drosophila wing vein development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>126</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>2663</sb:first-page><sb:last-page>2676</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0080">Guichard, A., Biehs, B., Sturtevant, M.A., Wickline, L., Chacko, J., Howard, K., Bier, E., 1999. rhomboid and Star interact synergistically to promote EGFR/MAPK signaling during Drosophila wing vein development. Development 126, 2663-2676.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>Haselton et&#160;al., 2010</ce:label><sb:reference id="sref15"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Haselton</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Sharmin</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Schrader</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Sah</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Poon</ce:surname></sb:author><sb:author><ce:given-name>Y.W.</ce:given-name><ce:surname>Fridell</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Partial ablation of adult Drosophila insulin-producing neurons modulates glucose homeostasis and extends life span without insulin resistance</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Cycle</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>3063</sb:first-page><sb:last-page>3071</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0085">Haselton, A., Sharmin, E., Schrader, J., Sah, M., Poon, P., Fridell, Y.W., 2010. Partial ablation of adult Drosophila insulin-producing neurons modulates glucose homeostasis and extends life span without insulin resistance. Cell cycle 9, 3063-3071.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>Heumann et&#160;al., 2000</ce:label><sb:reference id="sref16"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Heumann</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Goemans</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Bartsch</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Lingenhohl</ce:surname></sb:author><sb:author><ce:given-name>P.C.</ce:given-name><ce:surname>Waldmeier</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Hengerer</ce:surname></sb:author><sb:author><ce:given-name>P.R.</ce:given-name><ce:surname>Allegrini</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schellander</ce:surname></sb:author><sb:author><ce:given-name>E.F.</ce:given-name><ce:surname>Wagner</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Arendt</ce:surname></sb:author><sb:author><ce:given-name>R.H.</ce:given-name><ce:surname>Kamdem</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Obst-Pernberg</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Narz</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Wahle</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Berns</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J.&#160;Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>151</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>1537</sb:first-page><sb:last-page>1548</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0090">Heumann, R., Goemans, C., Bartsch, D., Lingenhohl, K., Waldmeier, P.C., Hengerer, B., Allegrini, P.R., Schellander, K., Wagner, E.F., Arendt, T., Kamdem, R.H., Obst-Pernberg, K., Narz, F., Wahle, P., Berns, H., 2000. Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration. The Journal of cell biology 151, 1537-1548.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>Iborra et&#160;al., 2011</ce:label><sb:reference id="sref17"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Iborra</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Soto</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Stark-Aroeira</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Castellano</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Alarcon</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Alonso</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Santos</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Fernandez-Malave</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>H-ras and N-ras are dispensable for T-cell development and activation but critical for protective Th1 immunity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Blood</sb:maintitle></sb:title><sb:volume-nr>117</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>5102</sb:first-page><sb:last-page>5111</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0095">Iborra, S., Soto, M., Stark-Aroeira, L., Castellano, E., Alarcon, B., Alonso, C., Santos, E., Fernandez-Malave, E., 2011. H-ras and N-ras are dispensable for T-cell development and activation but critical for protective Th1 immunity. Blood 117, 5102-5111.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>Inoki et&#160;al., 2002</ce:label><sb:reference id="sref18"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Inoki</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Zhu</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Wu</ce:surname></sb:author><sb:author><ce:given-name>K.L.</ce:given-name><ce:surname>Guan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>648</sb:first-page><sb:last-page>657</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0100">Inoki, K., Li, Y., Zhu, T., Wu, J., Guan, K.L., 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4, 648-657.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>Jancik et&#160;al., 2010</ce:label><sb:reference id="sref19"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Jancik</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Drabek</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Radzioch</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Hajduch</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Clinical relevance of KRAS in human cancers</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J.&#160;Biomed. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>2010</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>150960</sb:first-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0105">Jancik, S., Drabek, J., Radzioch, D., Hajduch, M., 2010. Clinical relevance of KRAS in human cancers. J Biomed Biotechnol 2010, 150960.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>Johnston et&#160;al., 1999</ce:label><sb:reference id="sref20"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.A.</ce:given-name><ce:surname>Johnston</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Prober</ce:surname></sb:author><sb:author><ce:given-name>B.A.</ce:given-name><ce:surname>Edgar</ce:surname></sb:author><sb:author><ce:given-name>R.N.</ce:given-name><ce:surname>Eisenman</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Gallant</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Drosophila myc regulates cellular growth during development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>98</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>779</sb:first-page><sb:last-page>790</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0110">Johnston, L.A., Prober, D.A., Edgar, B.A., Eisenman, R.N., Gallant, P., 1999. Drosophila myc regulates cellular growth during development. Cell 98, 779-790.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>Koera et&#160;al., 1997</ce:label><sb:reference id="sref21"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Koera</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Nakamura</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Nakao</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Miyoshi</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Toyoshima</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Hatta</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Otani</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Aiba</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Katsuki</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>K-ras is essential for the development of the mouse embryo</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Oncogene</sb:maintitle></sb:title><sb:volume-nr>15</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>1151</sb:first-page><sb:last-page>1159</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0115">Koera, K., Nakamura, K., Nakao, K., Miyoshi, J., Toyoshima, K., Hatta, T., Otani, H., Aiba, A., Katsuki, M., 1997. K-ras is essential for the development of the mouse embryo. Oncogene 15, 1151-1159.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>Kondo and Ueda, 2013</ce:label><sb:reference id="sref22"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Kondo</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Ueda</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Highly improved gene targeting by germline-specific Cas9 expression in Drosophila</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genetics</sb:maintitle></sb:title><sb:volume-nr>195</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>715</sb:first-page><sb:last-page>721</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0120">Kondo, S., Ueda, R., 2013. Highly improved gene targeting by germline-specific Cas9 expression in Drosophila. Genetics 195, 715-721.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>Larive et&#160;al., 2012</ce:label><sb:reference id="sref23"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.M.</ce:given-name><ce:surname>Larive</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Abad</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Cardaba</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Hernandez</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Canamero</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>de Alava</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Santos</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Alarcon</ce:surname></sb:author><sb:author><ce:given-name>X.R.</ce:given-name><ce:surname>Bustelo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Biol. Cell</sb:maintitle></sb:title><sb:volume-nr>23</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>2373</sb:first-page><sb:last-page>2387</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0125">Larive, R.M., Abad, A., Cardaba, C.M., Hernandez, T., Canamero, M., de Alava, E., Santos, E., Alarcon, B., Bustelo, X.R., 2012. The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development. Mol Biol Cell 23, 2373-2387.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>Lizcano and Alessi, 2002</ce:label><sb:reference id="sref24"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Lizcano</ce:surname></sb:author><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Alessi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The insulin signalling pathway</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Biol. : CB</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>R236</sb:first-page><sb:last-page>R238</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0130">Lizcano, J.M., Alessi, D.R., 2002. The insulin signalling pathway. Current biology : CB 12, R236-R238.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib25"><ce:label>Ma et&#160;al., 2005</ce:label><sb:reference id="sref25"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Ma</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Erdjument-Bromage</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Tempst</ce:surname></sb:author><sb:author><ce:given-name>P.P.</ce:given-name><ce:surname>Pandolfi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>121</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>179</sb:first-page><sb:last-page>193</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0135">Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., Pandolfi, P.P., 2005. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib26"><ce:label>Movilla et&#160;al., 1999</ce:label><sb:reference id="sref26"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Movilla</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Crespo</ce:surname></sb:author><sb:author><ce:given-name>X.R.</ce:given-name><ce:surname>Bustelo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Oncogene</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>5860</sb:first-page><sb:last-page>5869</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0140">Movilla, N., Crespo, P., Bustelo, X.R., 1999. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins. Oncogene 18, 5860-5869.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib27"><ce:label>Ohba et&#160;al., 2000</ce:label><sb:reference id="sref27"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Ohba</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Mochizuki</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yamashita</ce:surname></sb:author><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Chan</ce:surname></sb:author><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Schrader</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hattori</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Nagashima</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Matsuda</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J.&#160;Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>275</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>20020</sb:first-page><sb:last-page>20026</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0145">Ohba, Y., Mochizuki, N., Yamashita, S., Chan, A.M., Schrader, J.W., Hattori, S., Nagashima, K., Matsuda, M., 2000. Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3. The Journal of biological chemistry 275, 20020-20026.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib28"><ce:label>Oldham and Hafen, 2003</ce:label><sb:reference id="sref28"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Oldham</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Hafen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Trends Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>79</sb:first-page><sb:last-page>85</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0150">Oldham, S., Hafen, E., 2003. Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. Trends in cell biology 13, 79-85.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib29"><ce:label>Orme et&#160;al., 2006</ce:label><sb:reference id="sref29"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Orme</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Alrubaie</ce:surname></sb:author><sb:author><ce:given-name>G.L.</ce:given-name><ce:surname>Bradley</ce:surname></sb:author><sb:author><ce:given-name>C.D.</ce:given-name><ce:surname>Walker</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Leevers</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Input from Ras is required for maximal PI(3)K signalling in Drosophila</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1298</sb:first-page><sb:last-page>1302</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0155">Orme, M.H., Alrubaie, S., Bradley, G.L., Walker, C.D., Leevers, S.J., 2006. Input from Ras is required for maximal PI(3)K signalling in Drosophila. Nature cell biology 8, 1298-1302.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib30"><ce:label>Pacold et&#160;al., 2000</ce:label><sb:reference id="sref30"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.E.</ce:given-name><ce:surname>Pacold</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Suire</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Perisic</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Lara-Gonzalez</ce:surname></sb:author><sb:author><ce:given-name>C.T.</ce:given-name><ce:surname>Davis</ce:surname></sb:author><sb:author><ce:given-name>E.H.</ce:given-name><ce:surname>Walker</ce:surname></sb:author><sb:author><ce:given-name>P.T.</ce:given-name><ce:surname>Hawkins</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Stephens</ce:surname></sb:author><sb:author><ce:given-name>J.F.</ce:given-name><ce:surname>Eccleston</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Williams</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>103</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>931</sb:first-page><sb:last-page>943</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0160">Pacold, M.E., Suire, S., Perisic, O., Lara-Gonzalez, S., Davis, C.T., Walker, E.H., Hawkins, P.T., Stephens, L., Eccleston, J.F., Williams, R.L., 2000. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103, 931-943.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib31"><ce:label>Potenza et&#160;al., 2005</ce:label><sb:reference id="sref31"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Potenza</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Vecchione</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Notte</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>De Rienzo</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Rosica</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Bauer</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Affuso</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>De Felice</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Russo</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Poulet</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Cifelli</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>De Vita</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Lembo</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Di Lauro</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO Rep.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>432</sb:first-page><sb:last-page>437</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0165">Potenza, N., Vecchione, C., Notte, A., De Rienzo, A., Rosica, A., Bauer, L., Affuso, A., De Felice, M., Russo, T., Poulet, R., Cifelli, G., De Vita, G., Lembo, G., Di Lauro, R., 2005. Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO Rep 6, 432-437.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib32"><ce:label>Prober and Edgar, 2000</ce:label><sb:reference id="sref32"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Prober</ce:surname></sb:author><sb:author><ce:given-name>B.A.</ce:given-name><ce:surname>Edgar</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ras1 promotes cellular growth in the Drosophila wing</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>100</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>435</sb:first-page><sb:last-page>446</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0170">Prober, D.A., Edgar, B.A., 2000. Ras1 promotes cellular growth in the Drosophila wing. Cell 100, 435-446.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib33"><ce:label>Prober and Edgar, 2002</ce:label><sb:reference id="sref33"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Prober</ce:surname></sb:author><sb:author><ce:given-name>B.A.</ce:given-name><ce:surname>Edgar</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Interactions between Ras1, dMyc, and dPI3K signaling in the developing Drosophila wing</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genes Dev.</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>2286</sb:first-page><sb:last-page>2299</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0175">Prober, D.A., Edgar, B.A., 2002. Interactions between Ras1, dMyc, and dPI3K signaling in the developing Drosophila wing. Genes &amp; Development 16, 2286-2299.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib34"><ce:label>Rajalingam et&#160;al., 2007</ce:label><sb:reference id="sref34"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Rajalingam</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schreck</ce:surname></sb:author><sb:author><ce:given-name>U.R.</ce:given-name><ce:surname>Rapp</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Albert</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ras oncogenes and their downstream targets</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochim. Biophys. Acta Mol. Cell Res.</sb:maintitle></sb:title><sb:volume-nr>1773</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>1177</sb:first-page><sb:last-page>1195</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0180">Rajalingam, K., Schreck, R., Rapp, U.R., Albert, S., 2007. Ras oncogenes and their downstream targets. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1773, 1177-1195.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib35"><ce:label>Rosario et&#160;al., 1999</ce:label><sb:reference id="sref35"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Rosario</ce:surname></sb:author><sb:author><ce:given-name>H.F.</ce:given-name><ce:surname>Paterson</ce:surname></sb:author><sb:author><ce:given-name>C.J.</ce:given-name><ce:surname>Marshall</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>1270</sb:first-page><sb:last-page>1279</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0185">Rosario, M., Paterson, H.F., Marshall, C.J., 1999. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. The EMBO journal 18, 1270-1279.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib36"><ce:label>Rosario et&#160;al., 2001</ce:label><sb:reference id="sref36"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Rosario</ce:surname></sb:author><sb:author><ce:given-name>H.F.</ce:given-name><ce:surname>Paterson</ce:surname></sb:author><sb:author><ce:given-name>C.J.</ce:given-name><ce:surname>Marshall</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Activation of the Ral and phosphatidylinositol 3&#x2019; kinase signaling pathways by the ras-related protein TC21</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>3750</sb:first-page><sb:last-page>3762</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0190">Rosario, M., Paterson, H.F., Marshall, C.J., 2001. Activation of the Ral and phosphatidylinositol 3&#x2019; kinase signaling pathways by the ras-related protein TC21. Mol Cell Biol 21, 3750-3762.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib37"><ce:label>Rubin and Spradling, 1982</ce:label><sb:reference id="sref37"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>G.M.</ce:given-name><ce:surname>Rubin</ce:surname></sb:author><sb:author><ce:given-name>A.C.</ce:given-name><ce:surname>Spradling</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Genetic transformation of Drosophila with transposable element vectors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>218</sb:volume-nr></sb:series><sb:date>1982</sb:date></sb:issue><sb:pages><sb:first-page>348</sb:first-page><sb:last-page>353</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0195">Rubin, G.M., Spradling, A.C., 1982. Genetic transformation of Drosophila with transposable element vectors. Science 218, 348-353.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib38"><ce:label>Sanz-Rodriguez et&#160;al., 2018</ce:label><sb:reference id="sref38"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Sanz-Rodriguez</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Gruart</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Escudero-Ramirez</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>de Castro</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Delgado-Garcia</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Wandosell</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Cubelos</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>R-Ras1 and R-ras2 are essential for oligodendrocyte differentiation and survival for correct myelination in the central nervous system</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J.&#160;Neurosci. : Off. J. Soc. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>38</sb:volume-nr></sb:series><sb:date>2018</sb:date></sb:issue><sb:pages><sb:first-page>5096</sb:first-page><sb:last-page>5110</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0200">Sanz-Rodriguez, M., Gruart, A., Escudero-Ramirez, J., de Castro, F., Delgado-Garcia, J.M., Wandosell, F., Cubelos, B., 2018. R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System. The Journal of neuroscience : the official journal of the Society for Neuroscience 38, 5096-5110.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib39"><ce:label>Schweitzer and Shilo, 1997</ce:label><sb:reference id="sref39"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schweitzer</ce:surname></sb:author><sb:author><ce:given-name>B.Z.</ce:given-name><ce:surname>Shilo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A&#160;thousand and one roles for the Drosophila EGF receptor</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Trends Genet. : TIG (Trends Genet.)</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>191</sb:first-page><sb:last-page>196</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0205">Schweitzer, R., Shilo, B.Z., 1997. A thousand and one roles for the Drosophila EGF receptor. Trends in genetics : TIG 13, 191-196.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib40"><ce:label>Sears et&#160;al., 2000</ce:label><sb:reference id="sref40"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Sears</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Nuckolls</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Haura</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Taya</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Tamai</ce:surname></sb:author><sb:author><ce:given-name>J.R.</ce:given-name><ce:surname>Nevins</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genes Dev.</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>2501</sb:first-page><sb:last-page>2514</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0210">Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., Nevins, J.R., 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes &amp; Development 14, 2501-2514.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib41"><ce:label>Simanshu et&#160;al., 2017</ce:label><sb:reference id="sref41"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.K.</ce:given-name><ce:surname>Simanshu</ce:surname></sb:author><sb:author><ce:given-name>D.V.</ce:given-name><ce:surname>Nissley</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>McCormick</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>RAS proteins and their regulators in human disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>170</sb:volume-nr></sb:series><sb:date>2017</sb:date></sb:issue><sb:pages><sb:first-page>17</sb:first-page><sb:last-page>33</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0215">Simanshu, D.K., Nissley, D.V., McCormick, F., 2017. RAS Proteins and Their Regulators in Human Disease. Cell 170, 17-33.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib42"><ce:label>Simon et&#160;al., 1991</ce:label><sb:reference id="sref42"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Simon</ce:surname></sb:author><sb:author><ce:given-name>D.D.</ce:given-name><ce:surname>Bowtell</ce:surname></sb:author><sb:author><ce:given-name>G.S.</ce:given-name><ce:surname>Dodson</ce:surname></sb:author><sb:author><ce:given-name>T.R.</ce:given-name><ce:surname>Laverty</ce:surname></sb:author><sb:author><ce:given-name>G.M.</ce:given-name><ce:surname>Rubin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ras1 and a putative guanine nucleoside exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title></sb:series><sb:date>1991</sb:date></sb:issue><sb:pages><sb:first-page>701</sb:first-page><sb:last-page>716</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0220">Simon, M.A., Bowtell, D.D., Dodson, G.S., Laverty, T.R., Rubin, G.M., 1991. Ras1 and a putative guanine nucleoside exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. Cell, 701-716.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib43"><ce:label>Slack et&#160;al., 2015</ce:label><sb:reference id="sref43"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Slack</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Alic</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Foley</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Cabecinha</ce:surname></sb:author><sb:author><ce:given-name>M.P.</ce:given-name><ce:surname>Hoddinott</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Partridge</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The ras-erk-ETS-signaling pathway is a drug target for longevity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>162</sb:volume-nr></sb:series><sb:date>2015</sb:date></sb:issue><sb:pages><sb:first-page>72</sb:first-page><sb:last-page>83</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0225">Slack, C., Alic, N., Foley, A., Cabecinha, M., Hoddinott, M.P., Partridge, L., 2015. The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity. Cell 162, 72-83.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib44"><ce:label>Strutt and Strutt, 2003</ce:label><sb:reference id="sref44"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Strutt</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Strutt</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>EGF signaling and ommatidial rotation in the Drosophila eye</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Biol. : CB</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>1451</sb:first-page><sb:last-page>1457</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0230">Strutt, H., Strutt, D., 2003. EGF signaling and ommatidial rotation in the Drosophila eye. Current biology : CB 13, 1451-1457.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib45"><ce:label>Voice et&#160;al., 1999</ce:label><sb:reference id="sref45"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.K.</ce:given-name><ce:surname>Voice</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Klemke</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Le</ce:surname></sb:author><sb:author><ce:given-name>J.H.</ce:given-name><ce:surname>Jackson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J.&#160;Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>274</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>17164</sb:first-page><sb:last-page>17170</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0235">Voice, J.K., Klemke, R.L., Le, A., Jackson, J.H., 1999. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. The Journal of biological chemistry 274, 17164-17170.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib46"><ce:label>Wang et&#160;al., 2000</ce:label><sb:reference id="sref46"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.H.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Simcox</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Campbell</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Dual role for Drosophila epidermal growth factor receptor signalling in early wing disc development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genes Dev.</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>2271</sb:first-page><sb:last-page>2276</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0240">Wang, S.H., Simcox, A., Campbell, G., 2000. Dual role for Drosophila epidermal growth factor receptor signalling in early wing disc development. Genes Dev. 14, 2271-2276.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib47"><ce:label>Wassarman et&#160;al., 1995</ce:label><sb:reference id="sref47"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Wassarman</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Therrien</ce:surname></sb:author><sb:author><ce:given-name>G.M.</ce:given-name><ce:surname>Rubin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The Ras signaling pathway in Drosophila</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Opin. Genet. Dev.</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>44</sb:first-page><sb:last-page>50</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0245">Wassarman, D.A., Therrien, M., Rubin, G.M., 1995. The Ras signaling pathway in Drosophila. Current opinion in genetics &amp; development 5, 44-50.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib48"><ce:label>Weinkove et&#160;al., 1999</ce:label><sb:reference id="sref48"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Weinkove</ce:surname></sb:author><sb:author><ce:given-name>T.P.</ce:given-name><ce:surname>Neufeld</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Twardzik</ce:surname></sb:author><sb:author><ce:given-name>M.D.</ce:given-name><ce:surname>Waterfield</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Leevers</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Regulation of imaginal disc cell size, cell number and organ size by Drosophila class I(A) phosphoinositide 3-kinase and its adaptor</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Biol. : CB</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>1019</sb:first-page><sb:last-page>1029</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0250">Weinkove, D., Neufeld, T.P., Twardzik, T., Waterfield, M.D., Leevers, S.J., 1999. Regulation of imaginal disc cell size, cell number and organ size by Drosophila class I(A) phosphoinositide 3-kinase and its adaptor. Current biology : CB 9, 1019-1029.</ce:source-text></ce:bib-reference><ce:bib-reference id="bib49"><ce:label>Zecca and Struhl, 2002</ce:label><sb:reference id="sref49"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zecca</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Struhl</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Subdivision of the Drosophila wing imaginal disc by EGFR-mediated signalling</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>129</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>1357</sb:first-page><sb:last-page>1368</sb:last-page></sb:pages></sb:host></sb:reference><ce:source-text id="srct0255">Zecca, M., Struhl, G., 2002. Subdivision of the Drosophila wing imaginal disc by EGFR-mediated signalling. Development 129, 1357-1368.</ce:source-text></ce:bib-reference></ce:bibliography-sec></ce:bibliography></ja:tail></ja:article></doc:document>